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1. Summary  
  
Small  RNAs  like  microRNAs  (miRNAs)  and  short  interfering  RNAs  (siRNAs)  are  21  to  23  nucleotide  
long  single-­‐stranded  molecules  that  are  assembled  together  with  proteins  of  the  Argonaute  family  
(Ago)  into  an  effector  complex  called  RISC  (RNA  induced  silencing  complex).  Thus  they  are  able  to  
regulate  cognate  mRNAs  through  reduction  of  their  stability  or  inhibition  of  their  translation.  
AU-­‐rich  elements  (AREs),  on  the  other  hand,  are  a  class  of   regulatory  sequences   in   the  3’-­‐UTR  of  
many  short-­‐lived  mRNAs.  They  are  mainly  destabilizing  motifs  that  target  the  RNA  for  degradation  
by   binding   different   cellular   proteins   (AU-­‐rich   binding   proteins,   AUBPs).   This   mechanism   is  
described   as   AU-­‐rich   mediated   decay.   The   AU-­‐rich   binding   protein   Tis-­‐11   is   the   homologue   of  
mammalian   Tristetraprolin   (TTP)   in   Drosophila.   Tis-­‐11   binds   AREs   of   RNAs   via   its   zinc-­‐finger  
domain   and  accelerates  deadenylation  and   the  decay  of   the   transcript.   Previously   a   genomewide  
screen  in  Drosophila  cell  culture  showed  that  tis-­11  is  also  involved  in  the  RNAi  pathway  (Dorner,  
Lum  et  al.,  2006).  
A  recent  publication  claimed  that  the  function  of  AREs  may  be-­‐  at  least  in  part-­‐  relayed  through  the  
miRNA  pathway  (Jing  et  al.,  2005).  We  have  revisited  this  hypothesis  using  Drosophila  cell  culture.  
In  contrast  to  their  results  we  found  no  evidence  that  the  miRNA  pathway  is  universally  required  
for  the  function  of  AREs.  In  Drosophila  S2  cells,  both  ARE-­‐containing  GFP  reporter  mRNAs  and  the  
endogenous  cecA1-­‐mRNA  were  resistant  to  depletion  of  the  mi/siRNA  factors  dcr-­1,  dcr-­2,  ago1  and  
ago2.  Moreover,   the  Drosophila  miRNA  originally  proposed   to   recognized  AU-­‐rich  elements,  miR-­‐
289,  is  not  even  detectably  expressed  in  flies  or  cultured  S2  cells.  In  addition  our  attempts  to  over-­‐
express  this  miRNA  from  its  genomic  hairpin  sequence  failed.  Thus,  this  sequence  cannot  serve  as  
link   between   the  miRNA   and   the   AU-­‐rich   element  mediated   silencing   pathways.   To   sum   up   our  
study  strongly  argue  that  AREs  can  function  independently  of  miRNAs.  
Additionally   we   could   demonstrate   in   cultured  Drosophila   cells   that   the   correct   functionality   of  
Ago2-­‐loaded  RNA  species  depends  on  Tis-­‐11,  while  it  has  no  influence  on  Ago1-­‐loaded  RNAs.  The  
effects   of   Tis-­‐11   and   Ago2   are   not   additive,   thus   the   two   factors   act   in   the   same   pathway.   Co-­‐
immunoprecipitation   experiments   displayed   both   isoforms   of   Tis-­‐11   as   associated   with   a   small  
fraction   of   Ago2   and   the   RNaseIII   enzyme   Dcr-­‐2,   but   not   with   the  methyltransferase   Hen1.   The  
association  of  Tis-­‐11  and  Ago2   is  RNA  dependent.  Furthermore  neither  miR-­‐277  nor   the  hairpin-­‐
derived   endo-­‐siRNA   (CG4068B)   are   stably   bound   to  Tis-­‐11.   Generally  miR-­‐277   is   predominantly  
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loading   into   the   effector   complexes   and  also   the  distribution  of   the  Ago2-­‐loaded  RNAs   is   altered  
when   tis-­11   is   inhibited.   And   after   depletion   of   tis-­11   we   could   observe   that   the   processing   of  
mature  miR-­‐277  is  diminished  compared  to  the  control.  Though  Ago2  protein  levels  did  not  appear  
to  be  changed  upon  depletion  of  tis-­11,  the  ago2-­‐mRNA  level  was  clearly  reduced.  As  a  result  highly  
repetitive  sequences  in  the  mRNAs  of  tis-­11  and  ago2  implied  an  indirect  effect  on  the  RNAi  system  









2.1 Various  mechanisms  to  control  mRNA  stability  
  
Gene  regulation  depends  on  the  interplay  among  elements  that  control  gene  expression  at  multiple  
steps  including  transcription,  mRNA  stability,  post-­‐transcriptional  processing  and  translation.  
All  functional  mRNAs  are  generally  composed  of  a  7-­‐methyl-­‐guanylate-­‐cap  structure  at  the  5’-­‐end,  a  
5’-­‐UTR,  a  coding  region,  a  3’-­‐UTR  and  the  poly  (A)-­‐tail,  a  stretch  of  100-­‐250  adenine  residues,  at  the  
3’-­‐end.  Gene  expression  is  often  regulated  by  elements   located  in  the  3’-­‐UTR  of  a  transcript.  Next  
there  are  two  major  regulatory  mechanisms  described  that  can  induce  the  destabilization  of  target  
mRNAs.  
  
2.1.1 AU-­rich  elements  
  
Due  to  the  presence  of  regulatory  sequences  in  some  vertebrate  transcripts  their  half-­‐life  can  vary  
from   20  min   to  more   than   24  h   (Brennan   and   Steitz   2001;   Sharova,   Sharov   et   al.   2009).   A   well  
studied   example   of   such   cis-­‐acting   sequence   elements   are   AU-­‐rich   elements   (AREs)   that   are   50-­‐
150  nt  long  and  rich  in  adenosine  and  uridine  bases.  Usually  they  are  located  in  the  3’-­‐UTR  of  many  
but  not  all  short-­‐lived  mRNAs  encoding  cytokines,  cell  cycle  regulators  and  inflammatory  mediators  
and  lead  to  their  destabilization  (Barreau,  Paillard  et  al.  2005;  Baou,  Jewell  et  al.  2009).  Shaw  and  
Kamen  et  al.  showed  that  ARE  from  the  cytokine  GM-­‐CSF  mRNA  caused  rapid  decay  when  inserted  
into   3’-­‐UTR   of   the   otherwise   stable   β-­‐globin-­‐mRNA.   They   promote   rapid   deadenylation   and  
subsequent  degradation  of  the  transcript,  this  mechanism  is  called  AU-­‐rich  mediated  decay  (AMD).  
AREs  are  evolutionary  conserved  and  regulate  gene  expression  in  all  mammalian  organisms,  as  well  
as  in  Saccharomyces  cerevisiae  and  Drosophila  melanogaster  (Beisang  and  Bohjanen  ;  Caput,  Beutler  
et   al.   1986;   Shaw   and  Kamen  1986).   Discovered  1986   in   the   3’-­‐UTR  of   TNFα-­‐mRNA,  AREs  were  
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Table  2-­1:  Classification  of  AREs  in  mammals.  
  
Class  of  ARE   Motif   Examples  
  




II   At  least  2  overlapping  copies  of  UUAUUUA(U/A)(U/A)-­‐








Different  sets  of  RNA-­‐binding  proteins,  so  called  AU-­‐rich  binding  proteins  (AUBPs),  can  be  recruited  
to  AREs  and  execute  differential  regulation  of  the  transcript.  The  majority  are  destabilizing  AUBPs,  
which   induce   AMD   when   bound   to   the   sequence   elements,   among   them   are   AUF1   and  
Tristetraprolin  (TTP).  TTP,  for  example,  can  bind  to  AREs  via  its  tandem  zinc-­‐finger  motif  and  acts  
as   a   suppressor   of   inflammation   in  mice   by   regulating   the   stability   of   the   cytokine   TNFα-­‐mRNA  
(Ciais,  Cherradi  et  al.   ;  Carballo,  Lai  et  al.  1998).  However   the  destabilizing  activity  of  TTP   is  not  
constitutive,   its   activity   is   inhibited   by   phosphorylation   in   a  mitogen-­‐dependent  manner.   Kinase  
MK2  modifies  TTP  during  immune  activation  and  as  a  result  allows  binding  of  14-­‐3-­‐3  proteins  that  
reduce  the  destabilizing  activity  of  TTP  by  lowering  its  affinity  to  bind  to  AREs  (Clement,  Scheckel  
et  al.  ;  Sandler  and  Stoecklin  2008).  
In   mammals   three   major   pathways   for   AMD   were   proposed   (Figure  2-­‐1).   In   the   first   pathway  
decapping  enzymes  such  as  Dcp1  and  Dcp2  are  recruited  by  AUBPs  to  the  transcript.  After  removal  
of   the   cap   structure   the   cellular   5’-­‐to-­‐3’   exoribonuclease   Xrn1/pacman   can   degrade   the   mRNA.  
AUBPs  recruit  endoribonucleases   in   the  second  pathway  that  cleave   the   transcript   internally  and  
the   emerging   fragments   can   be   degraded   by   cellular   exoribonucleases.   In   the   third,   cellular  
deadenylases  are  targeted  to  the  mRNA  to  remove  the  poly  (A)-­‐tail  and  then  the  exosome  can  carry  
out   the   3’-­‐to-­‐5’-­‐decay.   In   contrast   a   smaller   group   of   AUBPs,   for   example   HuR,   functions   by  
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Figure  2-­‐1:  Overview  of  the  three  pathways  of  AMD  in  eukaryotes.  
AUBPs  bind  to  AREs  in  3’-­‐UTR  of  the  transcript  and  promote  decay  by  either  recruiting  decapping  enzymes  or  
deadenylases.  After   removal  of   the  cap  structure  or   the  poly(A)-­‐tail,  exonucleases   like  Xrn1/pacman  or   the  
exosome  can  degrade  the  RNA  from  5’-­‐to-­‐3’  or   from  3’-­‐to-­‐5’   respectively.  The  mRNA  can  also  be   internally  
cleaved  by  endonucleases.  Figure  adapted  from  (von  Roretz  and  Gallouzi  2008).  
  
  
2.1.2 Small  non-­coding  RNAs  
  
Another  form  of  mRNA  degradation  involves  small  non-­‐coding  RNAs,  such  as  microRNAs  (miRNAs)  
and   short   interfering   (siRNAs).   The   latter   can   be   divided   into   exogenous   (exo)   and   endogenous  
(endo)   siRNAs.   Changes   in   levels   of   small   RNAs   are   associated   with   many   developmental   and  
physiological  defects.   Small  RNAs  are  precisely   regulated   in  vivo   by  modulating   the   rates  of   their  
biogenesis  and  turnover  (Ji  and  Chen).  
miRNAs  are  encoded  in  the  genome  and  transcribed  by  RNA  Polymerase  II  as  so  called  pri-­‐miRNAs  
that   are   sequentially   processed   (Figure  2-­‐2A).   Pri-­‐miRNAs   form   hairpins   with   imperfect  
complementarity   that  are  cleaved  by   the  nuclear  RNase  III  enzyme  Drosha  and   its  dsRBP  partner  
Pasha  generating  long  precursor  miRNAs  (pre-­‐miRNAs)  about  70  nt  in  length  (Lee,  Jeon  et  al.  2002;  
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with  a  partially  base-­‐paired  stem.  They  are  exported  into  the  cytoplasm  by  Exportin  5  and  further  
processed  by  the  cytoplasmic  RNase  III  enzyme  Dicer.   In  Drosophila,  Dicer-­‐1  gets  assistance  from  
its  partner  Loquacious  (Loqs,  isoform  Loqs-­‐B)  to  liberate  a  20-­‐24  nt  mature  miR/miR*-­‐duplex  from  
the  pre-­‐miRNA  (Grishok,  Pasquinelli  et  al.  2001;  Hutvagner,  McLachlan  et  al.  2001;  Ketting,  Fischer  
et  al.  2001).    
The  miRNA  duplex  is  loaded  into  an  effector  complex  with  Argonaute  proteins  called  RNA-­‐induced-­‐
silencing-­‐complex   (RISC).   In   flies   biogenesis   of   small   RNAs   is   uncoupled   from   the   subsequent  
loading  step  into  RISC  (Forstemann,  Horwich  et  al.  2007).  They  are  sorted  into  RISC  with  Ago1  or  
Ago2   according   to   their   intrinsic   structure   of   the   duplex.   miRNA   duplexes   typically   containing  
bulges   and  mismatches   bind   to   Ago1,   while   siRNAs   with   higher   complementarity   bind   to   Ago2.  
Depending  on   thermodynamic  characteristics  of   the  duplex,   the  miR*-­‐strand   is  degraded   to   form  
mature  RISC.    After  that  the  Ago1-­‐loaded  miRNA  can  bind  to  targets  in  the  3’-­‐UTR  of  mRNAs  with  
only  partial  complementarity  and  silence  gene  expression  by  inhibition  of  translation  or  induction  
of  degradation  (Ghildiyal  and  Zamore  2009).  
In  Drosophila  two  Dicer  (Dcr)  proteins  exist.  As  described  above  Dicer-­‐1  generates  mature  miRNAs  
whereas   Dicer-­‐2   converts   long   dsRNA   into   21  nt   siRNA   duplexes.   siRNAs   and   miRNAs   have   a  
common  structure  with  5’-­‐phosphate  groups  and  3’-­‐2nt-­‐overhangs  (Figure  2-­‐2B).  The  long  double-­‐
stranded  precursor  of   exo-­‐siRNAs   is   either   introduced   into   the   cell  with   the  purpose  of   inducing  
RNA  interference  (RNAi)  experimentally  or  appears  during  replication  of  certain  RNA  viruses  (Liu,  
Rand  et  al.  2003;  Lee,  Nakahara  et  al.  2004;  Ghildiyal  and  Zamore  2009).  In  addition,  endo-­‐siRNAs  
that   are   from   endogenous   origin   can   be   produced   from   long   hairpin   structures  with   extensively  
paired   stretches,   convergent   transcription   or   cryptic   antisense   transcription   throughout   the  
genome.   The   endo-­‐siRNA   pathway   depends   on   Dcr-­‐2   and   the   dsRBP   Loqs   (isoform   Loqs-­‐PD)   in  
contrast  to  Dcr-­‐2  and  R2D2  in  the  exo-­‐siRNA  pathway.  Due  to  their  origin  from  a  long  dsRNA  siRNA  
precursors  are  perfectly  complementary  (Czech,  Malone  et  al.  2008;  Okamura,  Chung  et  al.  2008;  
Okamura  and  Lai  2008).  
  
Despite   their   distinct   biogenesis  miRNAs   and   siRNAs   participate   in   a   common   sorting   step   that  
loads  them  into  Ago1-­‐  or  Ago2-­‐effector  complexes.  The  RISC-­‐loading-­‐complex  (RLC),  consisting  of  
Dcr-­‐2  and  R2D2,  senses  the  thermodynamic  stability  of  the  5’-­‐ends  of  the  siRNA  duplex  and  binds  it  
in  a  directional  manner.  Then  the  RNA  is  delivered  to  RISC  with  Ago2,  because  of  their  high  degree  
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into  mature  RISC   by   degrading   the   nicked  passenger   fragments   (Liu,   Tan  et   al.   ;   Liu,   Rand   et   al.  
2003;  Pham  and  Sontheimer  2004;  Forstemann,  Horwich  et  al.  2007).  Mature  RISC  can  then  bind  to    
  
                                                                                     
  
Figure  2-­‐2:  Small  silencing  pathways  in  Drosophila.  
A)   miRNA   pathway.  miRNAs   are   encoded   in   the   genome   and   the   RNA   polymerase   II   primary   transcript   is  
cleaved  by   the  RNaseIII   enzyme  Drosha.  The   resulting   pre-­‐miR   is   exported   into   the   cytoplasm  and   further  
processed  by  the  second  RNaseIII  enzyme  Dcr-­‐1  with  the  help  of  its  dsRBP  Loqs-­‐PB.  This  cleavage  liberates  
the  miR/miR*  duplex  with  partial  complementarity  that  is  loaded  into  an  effector  complex  usually  comprising  
Ago1.  In  order  to  generate  mature  RISC  the  duplex  is  unwound  and  miR*  degraded.  RISC  can  bind  to  its  target  
sequences  and  repress  translation  or  trigger  destabilization.  
B)   siRNA  pathway.  Dcr-­‐2   generates   siRNAs   from  both   endogenous  and  exogenous  dsRNAs.  Exo-­‐siRNAs  are  
either   derived   from   long   dsRNAs   generated   during   viral   replication   or   long   dsRNAs   introduced  
experimentally.  Endo-­‐siRNAs  on  the  other  hand  can  derive  from  long  self-­‐complementary  hairpin  structures,  
convergent  transcription  or  antisense  transcription  throughout  the  genome.  The  dsRBP  R2D2  participates  in  
the   production   of   exo-­‐siRNAs,   in   contrast   for   endo-­‐siRNA   production   Loqs-­‐PD   is   required.   The   perfect  
complementary  duplex  is  loaded  by  the  RLC  (Dcr-­‐2  and  R2D2)  into  RISC  with  Ago2.  Cleavage  of  the  passenger  
strand   converts   pre-­‐RISC   into  mature   RISC.   DmHen1  methylates   the   siRNA   at   its   3’-­‐end   and   enhances   its  
stability.  Mature  RISC  can  cleave   targets  with  perfect  complementarity.  Figure  adapted   from  (Ghildiyal  and  
Zamore  2009)  
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target   sequences   with   perfect   complementarity   and   trigger   cleavage   of   the   mRNA   by   its   own  
endonucleolytic  (slicer)  activity.  In  Drosophila,  Ago2-­‐bound  RNAs  are  also  2’-­‐O-­‐methylated  at  their  
3’-­‐end   by   the   S-­‐adenosyl-­‐methionine   (SAM)-­‐dependent   methyltransferase   DmHen1   to   increase  
their  stability  (Horwich,  Li  et  al.  2007;  Saito,  Sakaguchi  et  al.  2007)see  also  chapter  4.9).  
The  minimal   RISC   complex   is   composed   of   Ago2   loaded   with   siRNA.   In   contrast   holo   RISC   is   a  
complex   composed   of   many   proteins   in   addition   to   Ago2.   For   example   Tudor   staphylococcal-­‐
nuclease-­‐domain-­‐containing   protein   (Tudor-­‐SN),   fragile-­‐X-­‐related   protein   (dFXR),   Vasa   intronic  
gene   product   (Vig)   and   a   homolog   of   p68   RNA   helicase   (Dmp68)   have   been   identified   as   RISC  
components  in  Drosophila.  However,  their  function  is  yet  unknown  (Martinez,  Patkaniowska  et  al.  
2002;  Tomari,  Matranga  et  al.  2004;  Dorner,  Lum  et  al.  2006).  
  
2.2 Crosstalk  between  the  small  RNA-­  and  ARE-­pathway  
  
Experimental  data  suggest  numerous  similarities  and  connections  between  the  small  RNA  pathway  
and  the  ARE  mediated  control  of  gene  expression  (reviewed  in   (Ciais,  Cherradi  et  al.   ;  von  Roretz  
and  Gallouzi  2008).  
Jing  et  al.  (Jing,  Huang  et  al.  2005)  postulated  in  their  publication  that  the  components  of  the  small  
RNA  silencing  system  Dicer-­‐1,  Ago1  and  Ago2  are  required  for  AMD  of  TNF-­‐α  mRNA  in  Drosophila  
and  human  cell  culture.  They  further  demonstrated  that  first  the  human  miR-­‐16  has  to  bind  to  the  
AREs  and  afterwards   recruit  RISC  and  TTP   to   the   transcript.   The  cooperation  of   small  RNAs  and  
AUBPs,  like  TTP,  is  essential  in  AMD.  They  further  claimed  that  miR-­‐289  supposedly  mediates  ARE  
recognition  in  Drosophila  Schneider  2  cells  (S2),  because  inhibition  of  miR-­‐289  leads  to  stabilization  
of  TNFα–mRNA.  
In  another  report  the  sequence  features  of  mRNAs  are  analyzed  after  depletion  of  Ago1  in  S2  cells.  
They   found   that   ARE-­‐genes   are   significantly   overrepresented   in   the   fraction   up-­‐regulated   after  
RNAi   of   Ago1.   Therefore   they   speculate   that   these   transcripts   might   be   influenced   by   both   the  
miRNA  machinery  and  AUBPs  (Hong,  Hammell  et  al.  2009).  
In  liver  cells  CAT1-­‐mRNA  is  targeted  by  miR-­‐122  and  located  into  P-­‐bodies  where  its  translation  is  
repressed.  However  upon  cellular  stress   the  AUBP  HuR  binds   to   the  ARE   in   the  3’-­‐UTR  of  CAT1-­‐
mRNA  and  forces  miR-­‐122  to  dissociate.  The  transcript  is  re-­‐located  into  cytoplasm  and  translation  
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In  mammals  miRNAs  may  also  negatively  regulate  TTP-­‐mediated  decay  through  their  competitive  
binding.  Ma  Cao  et  al.  analyzed  the  binding  behavior  of  TTP  and  miR-­‐3661  to  the  3’-­‐UTR  of   IL-­‐10  
mRNA  in  mammals.  Both  TTP  and  miR-­‐3661  compete  for  binding  to  AREs  of  the  transcript  and  both  
trigger  its  degradation.  But  the  decay  induced  by  miR-­‐3661  is  much  slower  than  that  of  TTP,  so  it  
finally  results  in  a  functional  stabilization  of  IL-­‐10  (Ma,  Liu  et  al.).  
Vasudevan   and   Steitz   (Vasudevan   and   Steitz   2007;   Vasudevan,   Tong   et   al.   2007)   found   in   their  
report   the  surprising   fact   that  human  Ago2  activates   translation  of  mRNAs  upon  cell   cycle  arrest  
caused  by  serum  starvation  or  contact  inhibition.  Mammalian  cells  exit  under  these  conditions  the  
cell   cycle   and   accumulate   in   G0-­‐phase,   called   quiescence.   There   the   RISC   associated   proteins  
Fragile-­‐X  mental  retardation-­‐related  protein  1  (FXR-­‐1)  and  Ago2,  usually  negative  regulators  of  the  
target,   are   transformed   into   effector  molecules   that   bind   ARE   to   activate   translation.   Moreover,  
miR369-­‐3p  directs  the  association  of  Ago2  and  FXR-­‐1  with  the  ARE.  
Finally  a  genomewide  screen  in  Drosophila  cell  culture  showed  that  tis-­11   is  involved  in  the  RNAi  
pathway.  Depletion  of   the  AUBP  Tis-­‐11   leads  to  a  stabilization  of   the   luciferase-­‐reporter  that  was  
shown  to  be  regulated  by  the  small  RNA  machinery  (Dorner,  Lum  et  al.  2006).  
  
2.3 AMD  in  Drosophila  melanogaster  
  
Most  research  on  AMD  is  done  in  mammals  and  very  little  is  known  about  the  mechanism  in  insects.    
A   computational  prediction   identified   conserved  AREs   in   the  3’-­‐UTR  of   transcripts   in  Drosophila.  
These   ARE   genes   are   enriched   in   various   cellular   and   developmental   processes   (Stark,   Lin   et   al.  
2007;  Cairrao,  Halees  et  al.  2009).  
Furthermore   the   components   of   the   mammalian   AMD   pathway   are   conserved   in   Drosophila,  
because   human   AREs   from   TNFα   and   IL-­‐6   3’-­‐UTRs   could   induce   the   decay   of   a   stable   β-­‐globin-­‐
mRNA  in  S2  cells.   In  addition  expression  of  mammalian  TTP  in  Schneider  cells  could  compensate  
the   effects   after   depletion   of   Tis-­‐11,   the   homologue   of   TTP   in  Drosophila.  Moreover   silencing   of  
Drosophila   specific  mRNA  decay   factors,   like  Tis-­‐11  and  Not1  stabilize  a  Luciferase-­‐reporter  with  
AREs  of  mouse  IL-­‐3  3’-­‐UTR  (Temme,  Zhang  et  al.  ;  Temme,  Zaessinger  et  al.  2004;  Jing,  Huang  et  al.  
2005;  Wei,  Xiao  et  al.  2009).  However   flies  are  not  only  capable   to   induce  AMD  but  also  use   this  
pathway  to  regulate  the  stability  of  endogenous  transcripts.  Eya-­‐mRNA  and  Vir1-­‐mRNA  are  among  
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examples  with  functional  AREs  in  their  3’-­‐UTR  in  Drosophila  (Spasic,  Friedel  et  al.  ;  Yeh,  Yang  et  al.  ;  
Cairrao,  Halees  et  al.  2009).  
The   immune   response   in  Drosophila   comprises   the   secretion   of   different   antimicrobial   peptides  
(AMPeps)  in  the  hemolymph  to  eliminate  pathogens.  CecA1  is  an  AMPep  transiently  induced  upon  
stimulation  of  S2  cells  with  E.coli  peptidoglycan.  The  transcripts  accumulate  rapidly  after  infection  
and  from  then  on  AMPep  levels  decrease.  CecA1  mRNA  is  short-­‐lived  due  to  AREs  in  the  3’-­‐UTR.  Tis-­‐
11   is   recruited   to   ARE   of   CecA1   and   promotes   rapid   degradation.   It   enhances   the   complete  
deadenylation   by   CCR4/CAF1/NOT1-­‐complex   and   therefore   triggers   decapping   and   decay   of   the  
CecA1  transcript  in  both  directions.  Finally  this  raises  the  question  if  Tis-­‐11  is  a  specific  or  general  
posttranscriptional   regulator   of   immune   genes   in   Drosophila   (Vindry,   Lauwers   et   al.   ;   Cairrao,  
Halees  et  al.  2009;  Lauwers,  Twyffels  et  al.  2009;  Wei,  Xiao  et  al.  2009).  
  
2.4 Goals  of  the  thesis  
  
As  already  known  is  miR-­‐277  predominantly  loaded  into  RISC  with  Ago2  (Forstemann,  Horwich  et  
al.  2007)  and  can  cleave  targets  with  perfect  complementarity.  But   it   cannot   repress  a   transcript  
with  imperfect  matches  to  the  miR-­‐277  sequence.  However,   there  are  no  perfect  matches  to  miR-­‐
277  in  the  whole  Drosophila  genome.  So  why  is  the  majority  of  miR-­‐277  is  loaded  into  an  effector  
complex  that  cannot  exert  the  necessary  function  in  the  fly?  
Two  recent  publications  showed  distinct  aspects  of  the  connection  between  miRNAs  and  AREs.  On  
the  one  hand,  factors  of  the  miRNA  pathway  are  required  for  AMD  in  Drosophila  cultured  cells  and  
on  the  other  hand  miRNAs  are  involved  in  translational  activation  of  mRNAs  under  certain  stress  
conditions  in  human  cells  (Jing,  Huang  et  al.  2005;  Vasudevan  and  Steitz  2007;  Vasudevan,  Tong  et  
al.  2007).  According  to  the  sequence,  miR-­‐277  has  the  potential  to  basepair  with  ARE  of  TNF-­‐α  3’-­‐
UTR  and  maybe  exerts  a  function  in  the  context  of  the  ARE  pathway.  We  wanted  to  further  examine  
this   hypothesis   and   in   general   the   connection   between   small   RNAs   and   ARE-­‐mediated   post-­‐
transcriptional  control  in  Drosophila.  
In  another  report  the  AUBP  Tis-­‐11  was  identified  in  S2  cells  as  involved  in  the  small  RNA  silencing  
system   (Dorner,   Lum   et   al.   2006).   Therefore,   we   wanted   to   elucidate   the   mechanism   of   Tis-­‐11  
action  in  the  biogenesis  and/or  the  function  of  small  RNAs.  
Materials  and  Methods  
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3. Materials  and  Methods  
  
3.1   Materials  
  
3.1.1      Laboratory  equipment  
  
90  µm  (45-­‐165  µm)  GSH-­‐Beads   GE  Healthcare  
Agarose  gel  running  chamber   Carl  Roth  GmbH;  Karlsruhe,  Germany  
BioLogic  LP  System   BioRad;  Hercules,  USA  
BioPhotometer   Eppendorf  AG;  Hamburg,  Germany  
Branson  Sonifier  250   Heinemann  Ultraschall  Labortechnik  
Centrifuge  5417  R   Eppendorf  AG;  Hamburg,  Germany  
Centrifuge,  Rotanta  460  R   Hettich  
Desk  Centrifuge,  220/230  VAC   Stuart  
FACSCalibur  flow  cytometer   Becton,  Dickinson;  Franklin  Lakes,  USA  
Filter,  GF  1-­‐2  µm   Rotilabo®  
Flow  buddy  CO2-­‐distributer   Genesee  Scientific;  San  Diego,  USA  
Fly  anesthetic  pad  and  pistol   Genesee  Scientific;  San  Diego,  USA  
Fraction  Collector  Model  2110   BioRad;  Hercules,  USA  
Gel  Photometer   Intas  
GSTrap™  High  Performance     GE  Healthcare  
Heater   HLC  
Incubator   WTC  binder  
Incubator  Shaker  Series   New  Brunswick  Scientific  
INTAS  UV  Imaging  System   INTAS;  Göttingen,  Germany  
LAS  3000  mini  Western  Imager   Fujifilm;  Tokyo,  Japan  
Leica  MZ7  stereomicroscope   Leica  Microsystems;  Wetzlar,  Germany  
Magnetic  Stirrer,  MR  3001   Heidolph  
Microplate  Reader  Infinite®  F500   Tecan  
Nanodrop   Thermo  Scientific  
Overhead  Shaker,  REAX  2   Heidolph  
Materials  and  Methods  
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PAGE-­‐electrophoresis   BioRad;  Hercules,  USA  
Power  supply   BioRad;  Hercules,  USA  
PVDF  Membrane  (0.45  micron  pore  size)   Thermo  Scientific  
Q  Sepharose™  High  Performance   GE  Healthcare  
Roller  Mixer,  SRT9   Stuart  
Semi-­‐dry  blotter  BioRad   BioRad;  Hercules,  USA  
Shaker,  Polymax  1040   Heidolph  Instruments  
SLC-­‐6000  Centrifuge   Eppendorf  AG;  Hamburg,  Germany  
Spectra/Por®   Dialysis   Membrane,   MWCO:  6-­‐
8,000  
Spectrum  Laboratories,  Inc.  
SpectroLinker  XL1500  UV  Crosslinker   Spectronics  Corporation;  Westbury,  USA  
SterilGARD  cell  culture  workbench   The  Baker  Company;  Sanford,  USA  
Table  top  centrifuge  (5417R  and  5415R)   Eppendorf  AG;  Hamburg,  Germany  
Tank-­‐blotting  chamber   BioRad;  Hercules,  USA  
Thermocycler  Sensoquest   Sensoquest;  Göttingen,  Germany  
TOptical  Thermocycler   Biometra;  Göttingen,  Germany  
Typhoon  9400  Variable  Mode  Imager   GE  Healthcare;  Freiburg,  Germany  
Vortex  Genie  2   Scientific  Industries  
Water  Bath   GFL  
Western  Blot  Imager  LAS  3000  mini   Fujifilm  
  
  
3.1.2      Laboratory  chemicals  
  
[γ  32P]  ATP  (SRP  501)  
10  mCi/ml;  6000  Ci/mmol;  250  μCi  
Hartmann  Analytic;  Braunschweig,  Germany  
2%  Triton   Sigma-­‐Aldrich  
Acrylamide  40%   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Agarose  Biozym   Biozym  Scientific  GmbH;  Oldendorf,  Germany  
Ammonium   peroxodisulfate   (Kapsimali,  
Kloosterman  et  al.)  
Roth  GmbH;  Karlsruhe,  Germany  
Ampicillin   Carl  Roth  GmbH;  Karlsruhe,  Germany  
APS   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Materials  and  Methods  
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Bacto  Agar   Becton,  Dickinson;  Franklin  Lakes,  USA  
Bis-­‐Tris  Propane   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Bovine  serum  albumin  (BSA)   New  England  Biolabs;  Ipswich,  USA  
Bradford  Assay   BioRad;  Hercules,  USA  
Chloramphenicol   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Chloroform   Merck   Biosciences   GmbH;   Schwalbach,  
Germany  
Complete®  without  EDTA  (Protease-­‐inhibitor)   Roche  Diagnostics;  Mannheim,  Germany  
Coomassie  G250   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Desoxyribonucleotides  (dA/C/G/TTP)   Sigma  Aldrich;  Taufkirchen,  Germany  
Dimethyl  sulfoxide  (DMSO)   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Dithiothreitol  (DTT)   Carl  Roth  GmbH;  Karlsruhe,  Germany  
ECL-­‐Solution   Thermo  Scientific  
Ethanol  (p.a.)   Merck   Biosciences   GmbH;   Schwalbach,  
Germany  
FACS  Flow/Clean/Rinse     Becton,  Dickinson;  Franklin  Lakes,  USA  
Fetal  bovine  serum  (FBS)     Thermo  Fisher  Scientific;  Waltham,  USA  
Formaldehyde   Sigma  Aldrich;  Taufkirchen,  Germany  
Formamide   Sigma  Aldrich;  Taufkirchen,  Germany  
Fugene®  HD  transfection  reagent   Roche  Diagnostics  GmbH;  Mannheim,  Germany  
Glutathion   Sigma-­‐Aldrich  
Glycerin   Carl  Roth  GmbH;  Karlsruhe,  Germany  
HEPES   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Isopropanol  (p.a.)   Merck   Biosciences   GmbH;   Schwalbach,  
Germany  
Kanamycin   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Methanol  (p.a.)   Merck   Biosciences   GmbH;   Schwalbach,  
Germany  
Polyacrylamide   National  diagnostics  
Powdered  milk   Rapilait  Migros;  Zürich,  Switzerland  
Sodium  dodecyl  sulphate  (SDS)   Merck   Biosciences   GmbH;   Schwalbach,  
Germany  
Syber  Safe/Gold  Invitrogen   Karlsruhe,  Germany  
TEMED   Carl  Roth  GmbH;  Karlsruhe,  Germany  
Triton  X-­‐100   Sigma  Aldrich;  Taufkirchen,  Germany  
Materials  and  Methods  
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Trizol   Invitrogen;  Karlsruhe,  Germany  
Tween  20   Carl  Roth  GmbH;  Karlsruhe,  Germany  
  
All  other  standard  laboratory  chemicals  were  purchased  from  the  Gene  Center  in  house  supply.  
  
  
3.1.3      Enzymes  
  
Polynucleotidekinase  (PNK)  with  Buffer   Fermentas;  St.  Leon-­‐Rot,  Germany  
Proteinase  K   Fermentas;  St.  Leon-­‐Rot,  Germany  
T4-­‐DNA  Ligase   New  England  Biolabs;  Ipswich,  USA  
Pfu  DNA  Polymerase   Fermentas;  St.  Leon-­‐Rot,  Germany  
Phusion  Hot  Start  DNA  Polymerase   Finnzymes  
Superscript  II,  Reverse  Transcriptase   Invitrogen;  Karlsruhe,  Germany  
T7-­‐polymerase   laboratory  stock  
Taq  DNA  Polymerase   laboratory  stock  
Restriction  enzymes    
BamHI  ,  NotI,  XbaI,  KpnI  
New  England  Biolabs;  Ipswich,  USA  
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3.1.4      Other  materials  
  
DyNAmo  Flash  SYBR  Green  qPCR  Kit   Finnzymes  
QIAGEN  Gel  extraction  Kit   Qiagen;  Hilden,  Germany  
QIAGEN  PCR  Purification  Kit   Qiagen;  Hilden,  Germany  
QIAGEN  Plasmid  Midi  Kit   Qiagen;  Hilden,  Germany  
QIAGEN  Plasmid  Mini  Kit   Qiagen;  Hilden,  Germany  
Sephadex  spin  column  (G25)   Roche  Diagnostics  GmbH;  Mannheim,  Germany  
Spin  column  (empty,  for  IP)   MoBiTec;  Göttingen,  Germany  
SuperSignal  West  Dura  Extended  Duration   Thermo  Fisher  Scientific;  Waltham,  USA  
Whatman  595  ½  Folded  Filters   Whatman  GmbH;  Dassel,  Germany  
Blotting  paper   Machery-­‐Nagel;  Düren,  Germany  
α-­‐Flag  affinity  agarose  A2220   Sigma  Aldrich;  Taufkirchen,  Germany  




3.1.5      Bacterial  cells  
  
E.  coli  BL21(DE3)pLysS   Laboratory  stock    
E.  coli  XL2-­‐blue  CaCl2-­‐competent  cells   Laboratory  stock    
  
All   E.   coli   strains   were   cultivated   in   LB-­‐medium   or   in   SOC-­‐medium   following   transformation.  
Antibiotic  containing  agar  plates  were  purchased  from  in-­‐house  supply.  
     
Materials  and  Methods  
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SOB-­‐medium  
0.5%  (w/v)  yeast  extract    
2%  (w/v)  Tryptone    
10  mM  NaCl  
2.5  mM  KCl  
10  mM  MgCl2    
10  mM  MgSO4    




20  mM  Glucose  
  
LB-­‐medium    
1%  (w/v)  Tryptone    
0.5%  (w/v)  yeast  extract    
1%  (w/v)  NaCl    
pH  7.2    
  
Antibiotics  added  to  medium  after  autoclaving  
100  μg/ml  ampicillin  (100  mg/ml  stock)    
10  μg/ml  kanamycin  (10  mg/ml  stock)    
25  μg/ml  chloramphenicol  (34  mg/ml  stock)  
  
  
3.1.6      Drosophila  melanogaster  cells  
  
63-­‐N1   endo-­‐siRNA  reporter   (Hartig,  Esslinger  et  al.  2009)    
67-­‐1D   siRNA  reporter;                                              
two  perfect  binding  sites  for  
miR-­‐277  in  GFP  3´-­‐UTR  
(Forstemann,   Horwich   et   al.  
2007)  
S2  B2   parental  cell  line   laboratory  stock  
  
Cell   culture  medium  and  additives   for  Drosophila   Schneider  cells  was  purchased   from  Bio  &  Sell  
(Nürnberg,   Germany)   and   supplemented   with   10%   heat-­‐inactivated   Fetal   Bovine   Serum   (FBS;  
Thermo  Fisher;  Waltham,  USA).  
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3.1.7      Fly  stocks  
  
Actin-­‐Gal4   Actin5C-­‐Gal4  driver  line   BL3954   Bloomington  Stock  center  




Bloomington  Stock  center  
Mef2-­‐Gal4   Muscle  specific  Gal4  driver  
line  
BL27390   Bloomington  Stock  center  
Mhc-­‐Gal4   Muscle  specific-­‐Gal4  driver  
line  
   received  from  Stefan  Sigrist  
Tubulin-­‐Gal4   Tubulin  Gal4  driver  line   BL5138   Bloomington  Stock  center  
VDRC101765   Tis-­‐11  RNAi   VDRC101765   VDRC  stock  center,  Vienna     
VDRC12259   Tis-­‐11  RNAi   VDRC12259   VDRC  stock  center,  Vienna     
w1118   recessive  white  mutation   BL6326   Bloomington  Stock  center  
  
  
3.1.8      Flyfood  
  
Standard  fly  food  was  obtained  from  in-­‐house  supply.  
5.8%  corn  meal    
5.5%  molasses    
2.4%  yeast  extract  
  
  
3.1.9      Plasmids  
  
pKF63   constitutive   myc-­‐GFP   expression  
under  ubiquitin-­‐promotor  control  
(Forstemann,   Tomari   et   al.  
2005)  
pUASTattB   conditional   expression   under   GAL4-­‐
control  
(Bischof,  Maeda  et  al.  2007)  
Materials  and  Methods  
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pUC18   transfection  control  vector   (Yanisch-­‐Perron,   Vieira   et  
al.  1985)  
pGEX-­‐6P-­‐1   for   recombinant   expression   of   GST-­‐
tagged  proteins    
Amersham/GE  Healthcare    
  
pUC18   transfection  control  vector   (Yanisch-­‐Perron,   Vieira   et  
al.  1985)  
pHSneo     neomycin   resistance   selection   of  
stable  cell  culture  lines    
  
pC5T   pCasper-­‐5  with  2kb  tubulin  promotor     
pSK2   pGEX-­‐6P-­‐1   for   expression   of   GST-­‐
tagged  Tis-­‐11PA  
  
pSH2   pKF63-­‐1xARE  (artificial  ARE  element)     
pSH3   pKF63-­‐2xARE  (artificial  ARE  element)     
pSH4   pKF63-­‐3xARE  (artificial  ARE  element)     
pSH5   pKF63-­‐TNF-­‐α  3’-­‐UTR  inverse     
pSH6   pKF63-­‐TNF-­‐α  3’-­‐UTR  ΔARE     
pSH7   pKF63-­‐IL-­‐6  3’-­‐UTR     
pSH8   pKF63-­‐IL-­‐8  3’-­‐UTR     
pSH9   pKF63-­‐TNF-­‐α  3’-­‐UTR     
pKF84   constitutive   expression   of   pre-­‐miR-­‐
277  
  
pSH12   constitutive   expression   of   pre-­‐miR-­‐
289  
  
Ban-­‐si   pKF63   2x   perfect   match   target   sites  
for  bantam  in  3’-­‐UTR  
(Shah   and   Forstemann  
2008)  
Ban-­‐mi   pKF63   4x   bulged   target   sites   for  
bantam  in  3’-­‐UTR  
(Shah   and   Forstemann  
2008)  
pSH13   pC5T-­‐myc2Tis-­‐11PA     
pSH15   pC5T-­‐myc2Tis-­‐11PB     
pSH23   Flag-­‐DmHen1     
pSH19   pUAST-­‐attB  Tis-­‐11PA     
pSH21   pUAST-­‐attB  Tis-­‐11PB     
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3.1.10     Oligonucleotides  
  
3.1.10.1     RNA-­Interference  
  
ds  dcr-­‐1   T7  dcr-­‐1_as   TAATACGACTCACTATAGGTTT  GGC  CGC  CGT  GCA  CTT  GGC  AAT  
   T7  dcr-­‐1_s   TAATACGACTCACTATAGGTTG  GGC  GAC  GTT  TTC  GAG  TCG  ATC  
ds  dcr-­‐2   T7  dcr-­‐2_as   TAATACGACTCACTATAGG  TTA  CAG  AGG  TCA  AAT  CCA  AGC  TTG  
   T7  dcr-­‐2_s   TAATACGACTCACTATAGG  CTG  CCC  ATT  TGC  TCG  ACA  TCC  CTC  C  
ds  DsRed   T7  DsRed_as   CGTAATACGACTCACTATAGGTGGTGTAGTCCTCGTTGTGG  
   T7  DsRed_s   CGTAATACGACTCACTATAGGAGGACGGCTGCTTCATCTAC  
ds  elav_2   T7  elav_2as   TAATACGACTCACTATAGGGAGATTTTGGGGAGGAGATTTGTG  
   T7  elav_2s   TAATACGACTCACTATAGGGAGACGCGTATCCCATTTTCATCT  
ds  elav_3   T7  elav_3as   TAATACGACTCACTATAGGGAGAAGTTGGGGATTGAGGAAAGC  
   T7  elav_3s   TAATACGACTCACTATAGGGAGACGACAAGTCGCAGGTCTACA  
ds  elav   T7  elav_as   TAATACGACTCACTATAGGGAGATCATTGTTTGCGGCAAGTAG  
   T7  elav_s   TAATACGACTCACTATAGGGAGACCCGATCCTCTCACCTATCA  
ds  fne   T7  fne_as   TAATACGACTCACTATAGGGAGATCGTTTAGCGTACAAATCAAATG  
   T7  fne_s   TAATACGACTCACTATAGGGAGACTGGCTGGCGATCTATTGG  
ds  msi   T7  msi_as   TAATACGACTCACTATAGGGAGATACTGCCCTTGCAGGAGTTT  
   T7  msi_s   TAATACGACTCACTATAGGGAGACGATACACGGAAGGCAAATTA  
ds  rbp6_2   T7  rbp6_2as   TAATACGACTCACTATAGGGAGAGCCGCCTGATAGTTGTTCAT  
   T7  rbp6_2s   TAATACGACTCACTATAGGGAGATGGTGACGAGAACGAAGAAA  
ds  rbp6   T7  rbp6_as   TAATACGACTCACTATAGGGAGAGCTGCGTTACACCCCCTA  
   T7  rbp6_s   TAATACGACTCACTATAGGGAGAAGTTCGCTGAGCGGATAGTG  
ds  rbp9   T7  rbp9_as   TAATACGACTCACTATAGGGAGATGAAAGTGGCTAGGCGAAGT  
   T7  rbp9_s   TAATACGACTCACTATAGGGAGATCGACTCTCCCGAAGAAAAA  
ds  Renilla  
Luciferase   T7  RLuci_as  
TAATACGACTCACTATAGGGAGAGGAATGATTTGATTGCCAAAAAT
AGG  
   T7  RLuci_s   TAATACGACTCACTATAGGGAGAATGAAACGATATGGGCTGAATAC  
ds  sqd   T7  sqd_as   TAATACGACTCACTATAGGGAGATAACCACCTCGTCCTCCGTA  
   T7  sqd_s   TAATACGACTCACTATAGGGAGAGATTCGCCTTCATCGTGTTT  
ds  tis-­‐11_2   T7  tis-­‐11_2as   TAATACGACTCACTATAGGGAGACCGTAATTCGGTCCTTCTCA  
   T7  tis-­‐11_2s   TAATACGACTCACTATAGGGAGAACAATAGCGTTGGCAGCAAG  
Materials  and  Methods  
  
  
   20  
ds  tis-­‐11_3   T7  tis-­‐11_3as   TAATACGACTCACTATAGGGAGACGCATTGTGAACAAAGTGACA  
   T7  tis-­‐11_3s   TAATACGACTCACTATAGGGAGAACTTGGGTGATTTCGATTGC  
ds  tis-­‐11_4   T7  tis-­‐11_4as   TAATACGACTCACTATAGGGAGACTACTGTTGCTACTTTGATTG  
   T7  tis-­‐11_4s   TAATACGACTCACTATAGGGAGACGATGAACACATCCAGATACAA  
ds  tis-­‐11_5   T7  tis-­‐11_5as   TAATACGACTCACTATAGGGAGACCTCCTGCTGCATCGGTGTGC  
   T7  tis-­‐11_5s   TAATACGACTCACTATAGGGAGACTGCCGCTAAGCCCACCGCT  
ds  tis-­‐11   T7  tis-­‐11_as   TAATACGACTCACTATAGGGAGACCATTCGATGCCAAATATCC  
   T7  tis-­‐11_s   TAATACGACTCACTATAGGGAGAATGCAAGTACGGCGAGAAGT  
  
  
3.1.10.2     Molecular  Cloning  
  
1xARE   NotI_1ARE_s   GGCCATTTTATTTATATTATTTA  


















UTRs  (Jing  et  al.)  
bglobin  
3’UTR_XbaI_as   TCTAGATAATTTTTGGCAGAGGGAAAAAGATC  


















myc2-­‐Tis11PA  &   Xba_tis11PA_PB_as   TCTAGATTAGAGTCCCAAATTGGACTGC  
Materials  and  Methods  
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-­‐PB  
OE  miR-­‐289   BamHI_pre289_s   GATGGATCCTAAGCAGGCAGCATGTCATC  
   Not_pre289_as   GCGGCCGCACCACTTCCAGCACGTTTTT  
recombinant  
Tis-­‐11PA   BamHI_tis11PA_s   CCAGGATCCTCTGCTGATATTCTGCAGAAA  
   EcoRI_tis11PA_as   CCAGAATTCTTAGAGTCCCAAATTGGACTG  
  
  
3.1.10.3     Quantitative  PCR  
  
   ago2  qPCR  as   GACGCAATGGTGACCTTCTT  
ago2   ago2  qPCR  s   TCAATGCCGATGATCGAATA  
CecA1   CecA1_fw  
GGATCCAAGCTTCCACGATGATTATTT
ATAA  
   CecA1_rev  
GGATCCTTCTTCTTTAAATTTTTAAAA
TT  
gapdh   gapdh_as   TGGACTCCACGATGTATTCG  
   gapdh_s   AATTTTTCGCCCGAGTTTTC  
GFP   GFP_1as   ACGTAAACGGCCACAAGTTC  
   GFP_1s   TCGTGACCACCCTGACCTAC  
rp49   rp49  A2   ATCGGTTACGGATCGAACA  
   rp49  B2   ACAATCTCCTTGCGCTTCTT  
tis-­‐11  qPCR_1   tis-­‐11  qPCR_1  as   GCTCCAGATCCACTGACCAC  
   tis-­‐11  qPCR_1  s   CAACAGTTCCGCCTCGTC  
tis-­‐11  qPCR_2   tis-­‐11  qPCR_2  as   CCAGGTTCTCGGTGATGGT  
   tis-­‐11  qPCR_2  s   GAGGTGCGCAAGGAAATAAG  
tis-­‐11  qPCR_3  (Cairrao  et  al.)   tis-­‐11  qPCR_3  as  
CGCTCGAGTTAGGCGCGGGCCTCGTCC
GCATTG  
   tis-­‐11  qPCR_3  s   CGTTCGAGGAGGCCGGAGAATGC  
  
     
Materials  and  Methods  
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3.1.10.4     Northern  Blotting  
  
2S-­‐rRNA     TACAACCCTCAACCATATGTAGTCCAAGCA  
bantam   AATCAGCTTTCAAAATGATCTCA  
CG4068B   GGAGCGAACTTGTTGGAGTCA  
miR-­‐277   TGTCGTACCAGATAGTGCATTTA  
miR-­‐277*   TGCAAATGCACTCCTGACACG  
miR-­‐289   AGTCGCAGGCTCCACTTAAATATTTA  
  
  
3.1.10.5   Antisense  Oligonucleotides  
  
as-­‐Luciferase     CAUCACGUACGCGGAAUACUUCGAAAUGUCC  
as-­‐miR-­‐277   UCUUGUCGUCCAGAUAGUGCAUUUACU  
as-­‐miR-­‐289   UCUAGUCGCAGGCUCCACUUAAAUAUUUACC  
  
The  constructs  are  5’-­‐cholesteryl-­‐modified  and  all  bases  are  2’-­‐O-­‐methyl  modified.  
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3.1.11     Antibodies  
  
3.1.11.1     Primary  antibodies  
  
α-­‐  β-­‐tubulin   mouse  β-­‐tub  E7   1:1000  Western  Blotting   DSHB  
α-­‐Ago1   mouse  1B8   1:1000  Western  Blotting   (Okamura,  Ishizuka  et  al.  
2004)  
α-­‐Ago2   rb  α-­‐Ago2     1:500  Western  Blotting   lab  generated  peptide  
antibody,  Davids    
α-­‐Dcr-­‐2   rb  α-­‐Dcr-­‐2   1:1000  Western  Blotting   abcam  
α-­‐flag   mouse  α-­‐flag  M2   1:1000  Western  Blotting   Sigma,  F1804  
α-­‐myc   mouse  α-­‐myc   1:1000  Western  Blotting     




3.1.11.2     Secondary  antibodies  
  
Goat  anti-­‐mouse  IgG  (H+L)  HRP-­‐coupled   1:20  000   Pierce  (Thermo  Scientific)    
Goat  anti-­‐rabbit  IgG  (H+L)  HRP-­‐coupled   1:50  000   Pierce  (Thermo  Scientific)    
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3.1.12     Commonly  used  buffers  and  stock  solutions  
  
Church  buffer                 1%  (w/v)     bovine  serum  albumine  (BSA)  
                  1  mM        EDTA  
0.5  M        phosphate  buffer    
7%  (w/v)     SDS    
pH  7.2    
  
Colloidal  Coomassie  staining  solution      50  g/l        aluminum  sulfate    
2%  (v/v)     H3PO4  (conc.)    
10%  (v/v)     ethanol    
0.5%  (v/v)     Coomassie  G250  stock  
  
DNA  loading  buffer  (6x)         0.25%  (w/v)     bromophenol  blue    
0.25%  (w/v)     xylene  cyanol    
30%  (w/v)     glycerol  
  
Dialysis  buffer               100  mM     KAc  
10  mM       HEPES  pH  7.4  
2  mM        MgAc  
5  mM        DTT  
  
Formamide  loading  dye  (2x)           80%  (w/v)     formamide    
10  mM       EDTA,  pH  8    
1  mg/ml     xylene  cyanol    
1  mg/ml     bromophenol  blue  
  
GST-­‐elution  buffer            50  mM       Tris  
20  mM       glutathione  
1  mM        DTT  
Materials  and  Methods  
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GST-­‐high  salt  buffer            1  x        PBS  
800  mM     NaCl  
1  mM        DTT  
  
GST-­‐low  salt  buffer            1  x        PBS  
20  mM       NaCl  
1  mM        DTT  
  
Laemmli  SDS  loading  buffer  (2x)        100  mM     Tris/HCl,  pH  6.8    
4%  (w/v)     SDS    
20%  (v/v)     glycerol    
0.2%  (w/v)     bromophenol  blue    
200  mM     DTT  (freshly  added)  
  
Lysis  buffer  for  protein  extraction        100  mM     KAc    
30  mM       HEPES  
2  mM        MgCl2    
1  mM        DTT    
1%  (v/v)     Triton  X-­‐100    
2x     Complete®  without  EDTA  (=protease  
inhibitor  cocktail)  
  
Lysis  Buffer  (GST-­‐purification)      1  x        PBS  
2  %  (v/v)   Triton  
500  mM     NaCl  
2x     Complete®  without  EDTA  (=protease  
inhibitor  cocktail)  
1  mM  DTT  
  
PBS-­‐T/TBS-­‐T                 PBS/TBS  supplemented  with  0.05%  Tween-­‐20    
  
SDS-­‐running  buffer  (5x)           125  mM     Tris/HCl,  pH  7.5    
1.25  M       glycine    
5%        SDS    
Materials  and  Methods  
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SSC  (20x)                 3  M        NaCl    
0.3  M        sodium  citrate  
  
TAE  (50x)                 2  M        Tris-­‐base    
5.71%       acetic  acid  (0,9  M)  
100  mM     EDTA    
  
TBE  (10x)                 0.9  M        Tris  base    
0.9  M        boric  acid    
0.5  M        EDTA      (pH  8)    
  
TBS  (10x)                 50  mM       Tris    
150  mM     NaCl    
pH  7.4    
  
Western  blotting  stock  (10x)           250  mM     Tris/HCl,  pH  7.5    
1.92  M       glycine    
  
Western  blotting  buffer  (1x)           10%        Western  blotting  stock  (10x)    
20%        methanol  
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3.2     Methods  
  
3.2.1     Methods  for  molecular  cloning  
  
3.2.1.1  Amplification  of  DNA  sequences  by  Polymerase  Chain  Reaction  (PCR)   
For  molecular  cloning  purposes  the  standard  reaction  mix  was  as  follows:    
  
Standard  reaction  mixture:  
1  µl        Template  DNA  
0.5  µl        forward  primer  (10µM)  
0.5  µl        reverse  primer  (10µM)  
5  µl        10x  Taq-­‐buffer  with  (NH4)2SO4  
4  µl        25  mM  MgCl2  
0.3  µl        Taq-­‐polymerase  
0.2  µl        Pfu-­‐Polymerase  
add  50  µl     H2O  
  
  
Standard  thermocycler  protocol:  
5  minutes  95°C  initial  denaturation  
35  cycles:   1  minute  95°C  denaturation  
           30  seconds  55°C  annealing  
1  minute  per  kb  product  size  72°C  extension  
5  minutes  72°C  final  extension  
storage  at  4°C  
  
According   to   the   length   of   nucleotides   to   be   separated   1   -­‐   1.5%   agarose   gels   (according   to   the  
expected   product   size)   were   prepared   with   1x   TAE   buffer   and   stained   with   1x   SyberSafe  
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(Invitrogen;  Karlsruhe,  Germany).  Gels  were  run  at  55  V  for  30  min  and  photographed  in  an  Intas  
UV   Imaging   System.   If   higher   sensitivity   was   required   gels   were   re-­‐stained   in   1x   SyberGold  
(Invitrogen;  Karlsruhe,  Germany)  for  15  min.    PCR  products  were  excised  and  purified  with  Qiagen  
Gel  Extraction  Kit.  
  
3.2.1.2  Specific  digestion  of  DNA  by  restriction  endonucleases  
Endonucleolytic   digestion   of   DNA  was   carried   out  with   restriction   endonucleases   acquired   from  
Fermentas   (St.   Leon-­‐Rot,   Germany)   and   New   England   Biolabs   (Ipswich,   USA)   ac-­‐   cording   to  
manufacturer’s   recommendations.   Usually,   reactions  were   incubated   for   1  hour   up   to   over   night  
incubation  at  37°C.  To  prevent  recircularization  the  cloning  vector  DNA  was  dephosphorylated  with  
FastAP   Thermosensitive   Alkaline   Phosphatase   (Fermentas;   St.   Leon-­‐Rot,   Germany)   according   to  
manufacturer’s  protocol.    
  
3.2.1.3  Ligation  of  vector  with  insert  DNA  
Digested  and  purified  insert  and  vector  were  combined  in  a  approximately  1:3  molar  ration:  
  
50-­‐  200ng     vector  
x    μl      insert  
2  μl        T4  buffer  (10x)  
1  μl        T4  DNA  Ligase    
add  20  μl     H2O    
  
Optimally  samples  were  ligated  over  night  at  18◦C  and  used  for  bacterial  transformation.    
  
3.2.1.4  Bacterial  transformation  
Transformation  of  competent  bacteria  was  carried  out  by  standard  heat  shock  procedures.  Briefly,  
50  μl  XL2-­‐blue  CaCl2-­‐competent  cells  were  thawed  on  ice.  1-­‐5  μl  of  ligation  sample  were  added  and  
the  mixture  was  incubated  on  ice  for  30  min,  subjected  to  a  1  min  heat  shock  at  42°C  and  returned  
to   ice  for  1  min.  500  μl  SOC-­‐medium  was  added  and  cells  were  allowed  to  grow  for  1  h  in  a  37°C  
shaking  incubator.  Cells  were  then  centrifuged  for  30  sec  at  full  speed  in  a  table  top  centrifuge,  the  
supernatant  was   poured   off   and   the   resuspended   cell   pellet  was   streaked   out   on   agarose   plates  
with  appropriate  antibiotics  for  selection  of  transformants.  
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3.2.1.5  Test  for  correct  transformants  by  colony-­PCR  
Individual   colonies  were   tested   for   correct   integration   of   the   insert   by   colony-­‐PCR  with   suitable  
primer   pairs.   A   standard   PCR   reaction   mix   was   inoculated   with   a   single   colony,   which   was  
subsequently  streaked  onto  a  fresh  plate  and  labeled  for   later  recognition.  Standard  amplification  
was  carried  out  with  10  min  initial  denaturing  for  cell  lysis  of  bacteria.  
  
3.2.1.6  Preparation  of  plasmid  DNA  
Plasmid  DNA  was  prepared   from  over-­‐night  cultures  of  2  ml  or  100  ml  LB-­‐medium,  respectively,  
supplemented  with   appropriate   antibiotics   (usually   100  μg/ml   ampicillin).   QIAGEN  Mini   or  Midi  
Kits  (Qiagen;  Hilden,  Germany)  were  used  according  to  the  manufacturer’s  protocols.    
  
3.2.1.7  DNA  sequencing    
The   correctness   of   the   sequences   of   the   gained   plasmids   was   verified   by   sequencing   (Eurofins  





3.2.2     Methods  with  Drosophila  Schneider  2  cells  
  
3.2.2.1  Maintenance  
Cells  were   cultured   in   Schneider´s  Medium   (Bio&Sell,   Nürnberg,   Germany)   containing   10%   heat  
inactivated  fetal  bovine  serum  (Thermo  Fisher  Scientific,  Waltham,  USA)  in  appropriate  cell  culture  
dishes  (Sarstedt,  Nümbrecht,  Germany).  Cells  were  split  once  to  twice  a  week  into  fresh  medium  for  
up  to  25  passages.  
  
3.2.2.2  RNA  interference  (RNAi)  
DsRNA   for  RNAi  was   generated  using   in   vitro   transcription   (IVT)  with  T7-­‐polymerase.  Therefore  
templates  of  the  genes  of  interest  were  used  in  which  T7-­‐promotor  sites  were  introduced  by  PCR  
and  afterwards   further   amplified  by  PCR  using  T7-­‐promotor  primer.  The   resulting  PCR  products  
were  applied  for  over-­‐night  in-­vitro  transcription  at  37°C.  
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IVT-­‐Mix:  
10  μl        T7-­‐template  DNA  
10  μl        10x  T7-­‐buffer  
0.5  μl        1  M  DTT  
5  μl        100  mM  ATP  
5  μl        100  mM  CTP  
5  μl        100  mM  UTP  
8  μl        100  mM  GTP  
2  μl        T7-­‐polymerase  
ad  100  μl     H2O  (54,5  µl)  
  
The  precipitate  of  magnesium  pyrophosphate,  which  formed  during  the  reaction,  was  pelleted  and  
the  dsRNA  was  precipitated  from  the  supernatant  with  1x  volume  of  isopropanol  and  washed  twice  
with   70%   ethanol.   The   pellet   was   air-­‐dried   and   re-­‐dissolved   in   100   μl   of   RNase-­‐free   H2O.   The  
sample   was   heated   to   95°C   for   5   minutes   and   slowly   cooled   down   to   room   temperature.  
Concentration  of   dsRNA  was   estimated   from  an  agarose   gel   in   comparison   to   a  DNA  Ladder  Mix  
(Fermentas;  St.  Leon-­‐Rot,  Germany).  
To  induce  a  knock  down  of  a  gene  of  interest  cells  were  seeded  at  0,5*106  cells/ml  and  12  µg  of  the  
corresponding  dsRNA  was   added   to   the  medium.  After   two  days   incubation  with   the  dsRNA  was  
repeated  and  on  day  7  the  resulting  GFP  fluorescence  of  the  reporter  cell  lines  was  determined  in  a  
Becton  Dickinson  FACSCalibur  flow  cytometer.  For  this  analysis  100  µl  of  cells  were  added  to  200  µl  
of  FACS  flow.  For  each  sample  10  000  cells  were  measured.  Analysis  of  fluorescence  intensity  was  
carried  out  with  CellQuest  software  (Becton  Dickinson;  Franklin  Lakes,  USA).  GFP-­‐negative  reporter  
cells   were   excluded   from   the   analysis   and   the   mean   fluorescence   value   for   each   sample   was  
determined.    
  
3.2.2.3  Transfection  of  plasmid  DNA  
,  2008).  
For  each  well  of  a  24-­‐well  cell   culture  dish  100-­‐500  ng  of   the  vector  of   interest  or  0.1  μl  of  2’-­‐O-­‐
methyl-­‐antisense-­‐oligo  (100  nM)  in  50  μl  medium  (without  serum)  and  4  μl  of  Fugene  Transfection  
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Reagent  (Roche  Diagnostics;  Mannheim,  Germany)  in  46  μl  of  medium  (without  serum)  were  mixed  
and   incubated  at  RT   for  1  hour.  Cells  were  added  to   the   transfection  mix  at  0.5   -­‐  1x  106  cells/ml  
medium  (+10%  FBS).  For  transfections  in  6-­‐wells  all  amounts  of  reagents  were  scaled  up.    
  
3.2.2.4  Selection  of  clonal  cell  lines    
To   create   cell   lines   that   stably   express   a   transgene   the   expression   plasmid   of   interest   was   co-­‐  
transfected  with  an  antibiotic  resistance  plasmid  into  cells  at  5-­‐10  x  105  cells/ml.  For  native  S2  cells  
10  ng  pHSneo  (for  neomycin  resistance)  were  used  together  with  200  ng  of  the  vector  of  interest.  
After  3  days,  cells  were  split  1:5  into  G418  containing  medium,  respectively.  The  concentration  was  
1.2  mg/ml  of  G418  for  neomycin  resistance.  Cells  were  split  1:5  once  a  week  for  4  weeks  to  obtain  
polyclonal  stable  cell  lines.  
  
3.2.2.5  Storage  of  cells  in  liquid  nitrogen    
Cell  stocks  were  frozen  by  adding  500  μl  cells  to  100  μl  Dimethylsulfoxide  (DMSO)  diluted  in  400  μl  
cell   culture   medium   (+10%   FBS)   in   a   Cryovial   (Biozym;   Oldendorf,   Germany).   Cryovials   were  
slowly   (1°C   per   hour)   cooled   to   -­‐80°C   in   an   isopropanol   freezing   container   (Nalgene/Thermo  
Fisher)  and  transferred  into  liquid  nitrogen  for  long-­‐term  storage.  
  
  
3.2.3     Protein  analysis  
  
3.2.3.1  Protein  extraction  
S2  cells  were  harvested  (2,500  x  g,  10  min)  and  washed  with  PBS.  The  pellet  was  resuspended  in  
lysis  buffer  (30  mM  HEPES,  100  mM  KOAc  pH  7.4,  2  mM  MgCl2,  1  mM  fresh  DTT,  1%  (v/v)  Triton  X-­‐
100,  2x  protease  inhibitor  cocktail   (Roche  Diagnostics  GmbH;  Mannheim,  Germany)  and  frozen  in  
liquid   nitrogen.   Samples   were   thawed   on   ice   and   cell   debris   were   pelleted   in   a   refrigerated  
microcentrifuge   (Eppendorf;   Hamburg,   Germany)   at   16   000   rpm.   Protein   concentrations   were  
determined  by  Bradford  assay  (BioRad;  Hercules,  USA).  
Fly  protein  was  extracted  by  grinding  flies  in  lysis  buffer  using  a  pistil  (Sigma  Aldrich;  Taufkirchen,  
Germany)  suitable  for  1.5  ml  reaction  tubes  and  subsequent  freeze-­‐thaw  lysis  analogous  to  S2  cells.    
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3.2.3.2  Dual  Luciferase  assay  
Cells   were   harvested   and   washed   with   1x   PBS.   Then   the   cell   pellet   was   resuspended   in   100   μl  
1x  Passive   Lysis   Buffer   (Promega).   After   centrifugation   (15  min,   1000   rpm)   the   protein   extracts  




30  μl  of  anti-­‐flag  or  anti-­‐myc  affinity  agarsoe  beads  per  IP  were  washed  three  times  in  1  ml   lysis  
buffer  respectively  and  incubated  with  1-­‐  2  mg  total  protein  in  lysis  buffer  at  4°C  for  30-­‐60  min  on  
an  overhead-­‐rotator.  If  desired  RNaseA  (50  μg/ml)  could  be  added  to  the  suspension.   -­‐
,  Germany)  and  washed  three  times  
with  500  μl  lysis  buffer.  The  bound  proteins  were  eluted  by  heating  the  samples  to  95°C  with  30  µl  
1x  Laemmli  buffer.  
Alternatively,  RNA  was  extracted  by  applying  200  μl  Trizol   (Invitrogen;  Karlsruhe,  Germany)  and  
following  the  manufacturer’s  instructions.  Before  precipitation  with  isopropanol  1.5  μl  of  glycogen  
were  added.  RNA  was  dissolved  in  10  μl  H2O.    
  
3.2.3.4  Western-­Blotting  
Western-­‐Blotting   was   performed   as   previously   described   in   (Forstemann,   Horwich   et   al.   2007).  
Briefly,  proteins  were  separated  using  10%  or  12  %  polyacrylamide  gels  for  90  minutes  at  150  V  in  
a   BioRad   electrophoresis   tank.   Proteins   were   transferred   to   a   polyvinylidenfluoride   (PVDF;  
Milipore;   Billerica,   USA)   membrane   by   tank   blotting   (300   mA   for   60   minutes).   Afterwards   the  
membrane  was  blocked  in  5%  milk  for  at   least  30  minutes  at  room  temperature.  Incubation  with  
primary  antibodies  was  carried  out  over  night  at  4°C  in  a  50  ml  Falcon  tube  using  2,5  ml  antibody  
dilution   in  1x  PBS/TBS-­‐solution  with  0,05%  Tween.   For   rabbit   antibodies  PBS-­‐T   (0.05%  Tween)  
was   used   during   all   following   washing   steps,   for   mouse   antibodies   TBS-­‐T   (0.05%   Tween)   was  
employed.  After  primary  antibody  binding   the  membrane  was  washed   three   times  10  minutes   in  
buffer   and   incubated  with   appropriate   secondary  antibody   for   at   least  2  h  at   room   temperature.  
After   three   times   washing,   Enhanced   Chemiluminescence   (ECL)   substrate   (Thermo   Fisher  
Scientific;  Waltham,  USA)  was  applied  and  the  resulting  signal  was  measured  in  an  LAS3000  mini  
Western  Imager  System  (Fujifilm;  Tokyo,  Japan).  If  necessary,  Western  blots  were  stripped  with  10  
ml  of  Restore  Stripping  Solution  (Thermo  Fisher  Scientific;  Waltham,  USA)  for  15  minutes  at  37°C  
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3.2.4     RNA  analysis  
  
3.2.4.1  RNA  isolation  
RNA   was   extracted   using   TRizol   (Invitrogen;   Carlsbad   /   CA,   USA)   from   cells   according   to   the  
manufacturer’s  instructions  and  quantified  using  spectrophotometry.  
  
3.2.4.2  β-­elimination  of  RNA  
40  µg  total  RNA  resolved  in  40.5  µl  H2O  was  incubated  with  12  µl  5x  borate  buffer  (148  mM  borax,  
148  mM   boric   acid   pH   8.6)   and   7.5   µl   NaIO4   (200mM   dissolved   in   H2O)   for   10   min   at   RT.   The  
oxidation  was  quenched  by  addition  of  6  µl  100%  glycerol  (10  min,  RT).  2M  NaOH  (5-­‐7  µl)  elavated  
the  pH  value  (ensure  that  pH=12).  After  90  min,  45°C  the  sample  was  transferred  to  a  Mini  quick  
spin  oligo  column  (Chen,  Larochelle  et  al.)  and  centrifuged  (12  000  g,  2  min).  20-­‐  40  µg  glycogen  
were  added  and  RNA  was  precipitated  with  3x  volume  100%  EtOH  (12  000  g,  15  min).  RNA  pellet  
was  washed  three  times  with  70%  EtOH  (last  step  4°C,  o/n)  and  dissolved  in  20  µl  2x  denaturating  
gel  loading  buffer.  The  samples  were  analyzed  by  Northern  blotting.  
  
3.2.4.3  Northern  blotting  
1-­‐5   µg   of   RNA   were   separated   on   a   20   %   Sequagel   Acrylamid-­‐Urea   Gel   (National   Diagnostics;  
Atlanta/USA)  at  200  V   for  1-­‐2  hours.  RNA  transfer  was  performed  on  a  Nylon  membrane  (Roche  
Diagnostics;  Mannheim,  Germany)  by  semi  dry  blotting  for  30  minutes  at  20  V.  Crosslinking  of  the  
RNA  to  the  membrane  was  achieved  by  radiation  with  UV-­‐light.  
Membranes  were  pre-­‐hybridized  in  Church  buffer  (1%  (w/v)  bovine  serum  albumine,  1  mM  EDTA,  
0.5   M   phosphate   buffer,   7%   (w/v)   SDS,   pH   7.2)   for   at   least   2   hours   at   37°C   in   an   oven   under  
constant   rotation.   The   probes   were   labeled   by   incubating   9   μl   H2O,   2   μl   10x   PNK   buffer,   2  μl  
5  mM  probe  oligonucleotide  (=10  pmol),  1  μl  PNK  (Fermentas)  and  6  μl  [γ-­‐32P]  ATP  for  1h  at  37°C.  
Unbound   radioactive   nucleotides   were   removed   using   a   Sephadex   G-­‐25   spin   column   (Roche  
Diagnostics;  Mannheim,  Germany).  
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Hybridization  with  labeled  as-­‐DNA-­‐probes  was  performed  overnight  at  37°C  in  5  ml  Church  buffer.  
Membranes   were   washed   three   times   for   15   minutes   with   2xSSC   0,1   %   SDS   and   exposed   on  
Phosphoimager  Screens   (FujiFilm;  Tokio,   Japan).   Screens  were  scanned  using  a  Typhoon  scanner  
(Amersham  Biosciences)  and  band  intensities  were  quantified  using  Multi  Gauge  software  (Fujifilm;  
Tokyo,  Japan).    
Stripping  of  the  membrane  was  achieved  by  dipping  it  into  boiling  1%  SDS  solution  and  incubating  
it   for   5  minutes   in   the   solution.   After   a   second   pre-­‐hybridization   the  membrane  was   reused   for  
hybridization  with  further  probes.  
  
3.2.4.4  Quantitative  RT-­PCR  (qRT-­PCR)  
100  ng  –  1  μg  of  total  RNA  extract  was  reverse  transcribed  according  to  the  Superscript  II  Reverse  
Transcriptase  protocol  (Invitrogen;  Karlsruhe,  Germany):  
   1  μg      oligo(dT)  (500  μg/ml)  
   x  μl      100ng  RNA  
   1  μl        dNTP  Mix  (10  mM  each)  
   add  12  μl   H2O  
  
The  mixture  was  heated  to  65◦C  for  5  min  and  quick  chilled  on  ice.  The  contents  of  the  tube  were  
briefly  centrifuged.  Then  following  components  were  added:    
   4  μl      5x  First-­‐Strand  Buffer  
   2  μl      0.1  M  DTT  
   1  μl      RiboLock  RNase  inhibitor  
   1  μl      SuperScript  II  RT  
  
The  contents  of   the   tube  were  mixed  gently  and   incubated  at  42°C   for  50  min.  The   reaction  was  
inactivated   by   heating   at   70°C   for   15  min.   100   μl   of   water  were   added   to   get   a   final   volume   of  
120  μl.  The  qPCR  reaction  mix  was  as  follows,  according  to  the  DyNAmo  Flash  SYBR  Green  qPCR  Kit  
(Finnzymes;  Finland).    
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Reaction  mix  for  one  well  of  a  96-­‐well  plate:  
   5  µl      Dynamo  Flash  Master  Mix  
   0.5  µl      Oligo_as  (10µM)  
   0.5  µl      Oligo_s  (10µM)  
   2.9  µl      H2O  
   0.1  µl      0.03%  Zylencyanolblau  
  
  
9µl  of  the  mastermix  solution  was  aliquoted  in  each  well  of  a  96  well  plate  using  an  8-­‐canal  pipette.  
1   µl   of   the   template   was   added   and   the   samples   cycled   on   an   TOptical   Thermocycler   using   the  
following  PCR-­‐program:  
  
3  min  95°C     initial  denaturation  
40  cycles:   1  min,  95°C     denaturation  
30  sec,  55°C     annealing  
30  sec,  72°C     extension  
  
Expression  was  quantified  with  the  2-­‐(ΔΔCt)  method  (Livak  and  Schmittgen  2001).  
  
  
3.2.5     Methods  with  flies  
  
3.2.5.1  Maintenance  and  handling  
The  fly  stocks  were  maintained  on  standard  agar  food  at  25°C  and  transferred  to  new  food  once  a  
week.  For  phenotype  selection  flies  were  anesthetized  with  CO2  and  sorted  on  a  CO2-­‐emitting  pad  
(Genesee   Scientific;   San   Diego,   USA)   using   a   Leica   MZ7   stereomicroscope   (Leica   Microsystems;  
Wetzlar,  Germany).  To  slow  proliferation  by  reducing  metabolic  rates  flies  were  kept  at  18°C  if  they  
were  not  used  for  a  current  experiment  and  were  transferred  to  new  food  every  4  weeks.  
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3.2.5.2  Generation  of  transgenic  flies    
The  myc2-­‐Tis-­‐11PA  and  myc2-­‐Tis-­‐11PB  constructs  were  sub-­‐cloned  into  pUASTattB  vector  and  sent  
for   injection   into   “zh-­‐86Fb“   (BL24749)   fly   embryos   (Rainbow   Transgenic   Flies;   Newbury   Park,  
USA).  This  fly  stock  carries  the  attP-­‐landing  site  on  the  3rd  chromosome  (3R  86F  genomic  location).  
Transgenic  offspring,  marked  by  red  eye  color,  were  twice  crossed  with  w1118  flies  to  reduce  the  
risk  of  secondary  mutations.  Siblings  were  then  mated  to  produce  homozygous  stable  lines.  
  
  
3.2.6     Recombinant  expression  and  purification  of  GST-­tagged  Tis-­11PA  
  
3.2.6.1  Recombinant  expression  of  GST-­Tis-­11PA  
The   100  ml   pre-­‐culture   (LB   medium,   100  µl  ampicillin,   100  µl  chloramphenicol,   0.5  %  glucose)  
inoculated  with  E.  coli  cells  transformed  with  pSK2  and  incubated  at  250  rpm  and  37°  C  over  night.  
The  6  l  expression  culture,  that  contained  appropriate  antibiotics,  was  inoculated  with  40  ml  of  pre-­‐
cultured  transformed  bacteria  (dilution  1:80).  After  cell  growth  to  OD600  =  0.6  at  37°  C  and  130  rpm  
in  baffled  flasks,  protein  expression  was  induced  by  adding  1  mM  IPTG.  After  incubating  for  4  hours  
at  37°  C,  the  bacteria  were  harvested  by  centrifugation  for  30  min  at  4500  rpm  at  4°  C.  The  obtained  
bacterial  pellets  were  suspended  in  300  ml  lysis  buffer  (1  x  PBS,  2  %  Triton,  500  mM  NaCl,  2  x  PI,  
1  mM  DTT)  and  stored  at  80  °  C.  
The  pellet  was  three  times  for  1  min  on  ice  resuspended  with  a  sonicator  (output  5-­‐6,  amplitude  20-­‐
30).  Afterwards,  the  solution  was  centrifuged  for  30  min  at  4500  rpm  at  4°  C.  Before  loading  on  the  
GSH-­‐beads,  the  supernatant  was  filtered  through  a  filter  (glass  fiber,  1-­‐2  μm  pore  size).  
  
3.2.6.2  Affinity  purification  of  recombinant  Tis-­11PA  
Purification   of   heterologous   Tis-­‐11PA   fused   to   GST   was   achieved   by   binding   to   glutathione,  
immobilized  to  a  sepharose  matix  (Glutathione  Sepharose  4-­‐Fast-­‐Flow  GSH-­‐beads).  3  ml  GSH-­‐beads  
were  previously  equilibrated  with  GST-­‐low  salt  (1x  PBS,  20  mM  NaCl,  1  mM  DTT  pH  7.0),  GST-­‐high  
salt   (1x   PBS,   800   mM   NaCl,   1   mM   DTT   pH   7.0)   and   again   low   salt   buffer.   Then   40  ml   protein  
solution  were   loaded   on   500  μL   GSH-­‐Beads   at   4°  C   over   night.   The   fractions   of   GSH-­‐beads  were  
collected  into  a  column.  The  column  was  washed  with  15  ml  low  salt,  15  ml  high  salt  and  10  ml  low  
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salt   buffer.   Afterwards,   the   column   was   incubated   with   15  ml   GST   elution   buffer   (50   mM   Tris,  
20  mM  glutathione,  1  mM  DTT  pH  8.0)  over  30  min.  
150  μg  of  the  PreScission  protease  were  added  to  the  elution  fraction  to  remove  the  GST-­‐tag  from  
Tis-­‐11PA.  The  15  ml  protein  solution  was  dialyzed  against  3  l  dialysis  buffer  (dilution  1:200)   in  a  
dialysis  membrane  with  molecular  weight  cut  off  of  6-­‐8  kDa,  while  stirring  at  4°  C  over  night.  
The   GSTrapTM   HP   column  was   previously   equilibrated   as   above.   Then   the   protein   solution   after  
dialysis  was  loaded  to  the  column.  The  GST-­‐tag  and  uncut  fusion  protein  bind  to  the  column  and  the  
desired  protein  Tis-­‐11PA  is  set  out  in  the  flow  through.  Afterwards,  the  uncut  protein  and  the  GST-­‐
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4. Results  
  
4.1 Artificial  and  authentic  mammalian  AREs  repress  GFP  reporters  in  
Drosophila  cells  
  
Jing  et  al.   (Jing,   Huang   et   al.   2005)   draw   the   conclusion   that  miRNAs   were   required   for   AU-­‐rich  
mediated  decay  (AMD)   in  mammals  and  Drosophila.   In  order   to  characterize   this   finding  more   in  
detail,  the  3’-­‐UTR  sequences  of  mammalian  TNF-­‐α,  IL-­‐6  and  IL-­‐8  mRNAs  -­‐  identical  to  those  used  in  
the  proposal  of   Jing  et  al.-­‐  were  inserted  downstream  of   the  GFP  coding  sequence   in  a  Drosophila  
expression  vector  (pKF63).  The  3’-­‐UTRs  of  TNF-­‐α  with  deleted  AREs  or  AREs  inserted  in  opposite  
orientation   were   used   as   controls.   In   addition   we   generated   constructs   with   one,   two   or   three  
repeats   of   an   artificial   ARE-­‐sequence,   which   resembles   that   of   the   interferon-­‐γ  mRNA  
(Worthington,  Pelo  et  al.  2002).  This  sequence  belongs  to  group  I  AREs  that  was  not  tested  for  its  
functionality  in  Drosophila  yet  (Figure  4-­‐1).  Stable  cells  were  selected  for  each  reporter  construct  to  




Figure  4-­‐1:  Schematic  representation  of  the  ARE-­reporter  constructs.  The  sequence  of  one  artificial  ARE  
is   indicated   5’   to   3’   (modelled   after   the   interferon-­‐γ   element).   One   repeat   of   artifical   ARE   is   depicted   as   a  
triangle  and  the  authentic  mammalian  3’-­‐UTRs  are  shown  as  arrows.  
  
  
Transcription  was  inhibited  with  α-­‐amanitin  and  RNA  was  isolated  at  different  time  points.  Thereby  
it   was   possible   to   examine   if   the   TNF-­‐α   mRNA   with   AREs   in   its   3’-­‐UTR   was   destabilized   and  





   40  
  
Figure   4-­‐3:   GFP-­reporter   cells   respond   to   depletion   of   the   AUBP   Tis-­11.   GFP   fluorescence   of   stable  
polyclonal   cell   lines   was   measured   by   flow   cytometry   and   normalized   to   control   knock-­‐down   targeting  
DsRed.  Values  are  mean  ±  SD  (n=3).  The  changes  were  significant  for  2xARE,  3xARE,  IL-­‐6  3’-­‐UTR  and  TNF-­‐  α  
3’-­‐UTR  when  compared  to  the  TNF-­‐αΔARE  control  (p<0.05,  student’s  t-­‐test,  n=4).  The  horizontal  line  marks  
no  change  compared  to  the  control.  
  
  
4.2 Depletion  of  mi/siRNA  factors  does  not  lead  to  de-­repression  of  ARE  
reporters  
  
If   miRNAs   indeed   participate   in   the   recognition   of   AREs,   then   GFP   fluorescence   should   be   de-­‐
repressed  upon  depletion  of  miRNA  biogenesis  factors.  Factors  of  the  small  RNA  biogenesis  system,  
dcr-­1,  dcr-­2,  ago1  and  ago2,  were  depleted  with  RNAi  in  stable  reporter  cells  and  the  GFP  signal  was  
measured.   GFP   levels   did   not   change   after   impairment   of   the   mi/siRNA   biogenesis   factors  
compared   to   the   control   knock-­‐down   directed   against   DsRed   (Figure  4-­‐4A   and   Figure  4-­‐4B).   In  
some   cases   there  was   a   slight  de-­‐repression   after  ago2   and  dcr-­2   silencing   detectable.   But   these  
changes  did  not  correlate  with  the  extent  of  de-­‐repression  observed  after  depletion  of  tis-­11  and  in  
addition  they  were  not  comparable  with  the  reported  effects  of  Jing  et  al.  
Furthermore   there   was   no   change   of   steady-­‐state   mRNA   levels   of   the   GFP-­‐3xARE   reporter   or  
CecropinA1   (CecA1),   an   endogenous  mRNA   that   contains   AREs,   after   depletion   of   dcr-­2   or   ago2  
(Figure  4-­‐5).   In  contrast,  silencing  of   tis-­11  significantly   increased   the  steady  state  mRNA   level  of  
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mRNAs  recognizable  since  de-­‐repression  upon  tis-­11  knock-­‐down  was  1.57  x  for  mRNA  and  1.61  x  




Figure   4-­‐4:   Response   of   stable   ARE-­reporter   cells   to   depletion   of   components   of   the   small   RNA  
silencing  pathway.  
A)  Silencing  of  dcr-­1  or  dcr-­2.  Stable  polyclonal  reporter  cells  were   treated  with  dsRNAs  targeting   dcr-­1  or  
dcr-­2.  The  resulting  GFP  signal  was  measured  by  flow  cytometry  and  normalized  to  DsRed  control.  Values  are  
mean  ±  SD  (n=3).  The  horizontal  line  marks  no  change  compared  to  the  control.  
B)  analogous  to  A)  depletion  of  ago1  or  ago2.  
  
In   theory   it   is   possible   that  during   selection  of   stable   cell   lines,   reporter   cells   somehow  gain   the  
ability  to  bypass  the  requirement  for  miRNAs  in  AMD  because  only  a  small  fraction  of  the  original  
population  is  retained.  To  exclude  this  we  measured  the  GFP  fluorescence  after  depletion  of  ago1,  
ago2,   dcr-­1   and   dcr-­2   in   cells   transiently   transfected   with   the   reporter   constructs.   In   this  
experiment   it  was  also  necessary   to  normalize   the  values   to   those  of   a   control   construct  without  
AREs   in   the   3’-­‐UTR   (pKF63).  Depletion  of   certain   cellular   factors   prior   to   transfection   can   cause  
toxic  side  effects  and  influence  the  efficiency,  because  in  most  of  the  cases  proliferation  rates  were  
changed.  But  this  additional  normalization  introduces  more  measurement  noise  (Figure  4-­‐6).  TNF-­‐
α-­‐   and   IL-­‐8-­‐reporter,   the   latter   did   not   respond   in   the   stable   cell   line,   were   de-­‐repressed   after  
silencing  of  tis-­11  in  transiently  transfected  cells.  A  similar  trend  could  be  observed  for  IL-­‐6  as  well  
as  for  all  three  artificial  ARE  reporter.  Again  silencing  of  the  small  RNA  biogenesis  factors  did  not  
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Figure  4-­‐5:  Analysis  of  mRNA  steady-­state  level  changes  upon  depletion  of  tis-­11,  ago2  and  dcr-­2.  
Quantitative  RT-­‐PCR  analysis  was  performed   for  the  indicated  transcripts  (cecA1  =  endogenous  ARE  target,  
GFP-­‐3xARE  =  stable  ARE  reporter,  rp49  =  ribosomal  protein  mRNA),  normalized  to  the  mRNA  levels  of  gapdh.  
Changes   were   calculated   relative   to   control   RNAi   directed   against   DsRed.   The   horizontal   line   marks   no  
change   compared   to   the   control.   The   asterisk   (*)   indicates   a   significant   change   relative   to   control   (p<0.03,  





Figure   4-­‐6:  Response  of   transiently   transfected  ARE-­reporter   cells   to   silencing  of  dcr-­1  or  dcr-­2   and  
ago1  or  ago2.  
Depletion   of  dcr-­1,  dcr-­2,   ago1   or  ago2   in   transiently   transfected   reporter   cells.   The  GFP   fluorescence  was  
measured  by  flow  cytometry  and  normalized  to  the  control  targeting  DsRed.  Values  are  mean  ±  SD  (n=3).  The  
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TNF-­‐α  reporter  was  repressed  by  Ago1,  Ago2,  Dcr-­‐1  and  Dcr-­‐2.  But  all  other  constructs  remained  
unaffected.   Hence   it   is   possible   that   under   certain   circumstances   miRNAs   can   function  
synergistically  with  ARE-­‐sequences,  but  there  could  be  no  general  requirement  of  miRNAs  for  AMD  
detected.   Taken   together   we   showed   that   the   small   RNA   silencing   system   is   not   universally  
required  for  ARE-­‐mediated  mRNA  degradation.  
  
  
4.3 Direct  inhibition  or  over-­expression  of  miR-­289  and  miR-­277  does  
not  influence  ARE-­reporters  
  
  
                                     
Figure  4-­‐7:  Repression  of  ARE-­reporter  cells  is  independent  of  miR-­289  activity.  
A)  miR-­‐289  and  miR-­‐277  were  inhibited  by  transfection  of  antisense  oligonucleotides   in  GFP-­‐reporter  cells  
(stable,  polyclonal)  and  miR-­‐277  reporter  cell  line  (stable,  monoclonal).  GFP  fluorescence  was  measured  by  
flow   cytometry   and   normalized   to   control   directed   against   part   of   the   firefly   luciferase   coding   sequence.  
Values  are  the  mean  of  two  experiments.  The  horizontal  line  marks  no  change  compared  to  the  control.  
B)   Response   of   ARE-­‐reporters   to   over-­‐expression   of   miR-­‐289   and   miR-­‐277   (transiently   transfected).   An  
unrelated  plasmid  (pUC18)  served  as  control  for  normalization.  Values  are  the  mean  of  two  experiments.  The  
horizontal  line  marks  no  change  compared  to  the  control.  
  
MiR-­‐289  was  identified  in  the  publication  of  Jing  et  al.  to  recognize  AREs  in  S2  cells.  To  revisit  this  
hypothesis   the   reporter   cells   were   treated   with   2’-­‐O-­‐methyl-­‐modified   RNA   oligonucleotides  
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directed   against   miR-­‐289   as   well   as   miR-­‐277,   a   second   Drosophila   miRNA   that   can   potentially  
basepair  with   ARE-­‐sequences.   Inhibition   of   both  miRNAs   did   not   lead   to   a   de-­‐repression   of   GFP  
fluorescence   in   any   of   the   reporter   constructs   (Figure  4-­‐7A).   As   expected   the  miR-­‐277   reporter  
construct  with  two  perfectly  complementary  target  sites  for  miR-­‐277  in  the  3’-­‐UTR  of  GFP  (pKF67)  
showed   a   strongly   enhanced   GFP-­‐signal   when   treated   with   the   miR-­‐277   inhibitor   (Forstemann,  
Horwich  et  al.  2007).  The  construct  is  specifically  silenced  by  miR-­‐277  because  GFP  is  not  stabilized  
after   treatment   with   the   miR-­‐289   inhibitor.   Furthermore,   over-­‐expression   of   the   miRNAs   from  
plasmids  generating  the  putative  hairpin  precursors  of  miR-­‐277  and  miR-­‐289  did  not  enhance  the  
repression  of  the  reporter  cells  (Figure  4-­‐7B).  
  




   45  
(figure  legend  continued  p.45)  
S2  cells  were  transfected  with  plasmids  over-­‐expressing  the  putative  hairpin  of  miR-­‐289  and  miR-­‐277.  pUC18  
served  as  a  control.  RNA  was  analyzed  by  Northern  blotting.  5  fmol  of  the  miR-­‐277  and  miR-­‐289  DNA  oligo  
were  also  loaded.  DNA  probes  against  miR-­‐289  (upper  panel)  and  miR-­‐277  (second  panel)  served  as  positive  
controls  for  the  hybridization.  bantam  (bottom  panel)  served  as  a  control  for  loading.  
  
In  addition  the  analysis  of  several  deep  sequencing  libraries  from  S2  cells  and  also  flies  (published  
by  the  modEncode  consortium  (mod,  Roy  et  al.))  did  not  provide  any  sequence  that  corresponds  to  
mature  miR-­‐289   (in   contrast   to  1.5x106   reads  matching   to  other  miRNAs   in  Drosophila,   data  not  
shown).  To  make  sure  that  this  finding  is  not  only  an  artefact  due  to  a  strong  unfavourable  cloning  
bias  for  the  deep  sequencing  libraries,  it  was  tested  by  Northern  blotting  if  miR-­‐289  is  expressed  in  
S2   cells   at   all   (Figure  4-­‐8).   The  Northern   blot  was   probed   for  miR-­‐289,  miR-­‐277   and   as   loading  
control   bantam.  Mature  miR-­‐289   could   not   be   detected   in   the   control   cells   transfected  with   the  
unrelated  control  pUC18.  As  a  positive  control,  5  fmol  of  the  miR-­‐289  control-­‐DNA-­‐oligonucleotide  
was  visible.  In  addition  miR-­‐289  was  not  detectable  in  cells  transfected  with  the  vector  expressing  
the   putative  miR-­‐289  hairpin   precursor   under   the   control   of   the   strong   ubiquitin   promotor.   For  
comparison  miR-­‐277  is  already  visible  in  the  control  cells  and  the  transfection  of  a  plasmid  driving  
the   expression   of   the  miR-­‐277  hairpin   precursor   resulted   in   a   strong   over-­‐expression   of  mature  
miR-­‐277.  To  sum  up  there  is  no  proof  for  the  existence  of  mature  miR-­‐289  in  Drosophila.  Hence  it  is  
unclear  how  this  sequence  could  be   identified  as   the  miRNA  necessary   for  ARE  recognition   in  S2  
cells  by  Jing  et  al.  
  
  
4.4 ARE-­binding  proteins  have  an  impact  on  miR-­277-­reporter  cells,  
primarily  targeted  by  Ago2-­RISC  
  
In   mammals   different   classes   of   proteins   that   can   bind   to   AREs   exist   and   lead   either   to  
destabilization   or   stabilization   of   the   corresponding   transcript   (Beisang   and   Bohjanen).   We  
depleted   several   Drosophila   homologues   of   HuR,   AUF   and   TTP   in   stable   reporter   cell   lines  











Figure  4-­‐9:  Depletion  of  some  Drosophila  AUBP  homologues  have  an  impact  on  miR-­277-­reporter  cells.  
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(figure  legend  continued  from  p.47)  
A)  Endo-­‐siRNA  reporter  cells   (63-­‐N1)  were   treated  twice  with  dsRNA  constructs   indicated  below  the  bars.  
Fne,  Elav,  Rbp9  are  homologues  of  the  mammalian  HuR;  Msi,  Rbp6,  Sqd  of  AUF  and  Tis-­‐11  is  the  homologue  of  
TTP.   Ago2   and   Dcr-­‐2   served   as   positive   controls.   GFP-­‐fluorescence  was  measured   by   flow   cytometry   and  
normalized  to  control  knock-­‐down  DsRed.  Values  are  the  mean  of  two  experiments.  The  horizontal  blue  line  
marks  no  change  compared  to  the  control.  
B)  analogous  to  A)  using  miR-­‐277  reporter  cells  (67-­‐1D),  with  two  perfectly  matching  sites  for  miR-­‐277  in  the  
3’UTR  of  GFP.  
  
Figure  4-­‐9   illustrates   the   mean   GFP   fluorescence   of   cells   after   seven   days   treatment   with   the  
corresponding   dsRNA,   measured   by   flow   cytometry   and   normalized   to   a   control   knock-­‐down  
targeting  DsRed.   In  Figure  4-­‐9A  the  response  of   the  cell   line  63-­‐N1  is  depicted,  which  serves  as  a  
suitable   reporter   for   the  endo-­‐siRNA  pathway.  Depletion  of  Ago2  and  Dcr-­‐2   leads   to  an  expected  
increase  in  fluorescence.  Both  are  major  components  of  the  siRNA  pathway  and  therefore  necessary  
for  the  functionality  of  the  siRNA  response.  There  was  no  significant  stabilization  of  GFP  observable  
for  the  seven  AUBPs.  So  they  all  seem  not  to  participate  in  endo-­‐siRNA  mediated  gene  silencing.  
However,  silencing  of  three  out  of  seven  AUBPs  resulted  in  a  de-­‐repression  of  the  GFP  fluorescence  
using  exo-­‐siRNA  reporter  cells  (67-­‐1D,  Figure  4-­‐9B).  They  contain  two  perfectly  matching  sites  for  
miR-­‐277  in  the  3’-­‐UTR  of  the  GFP  coding  sequence,  which  are  targeted  primarily  by  miR-­‐277  loaded  
into   RISC   with   Ago2.   Thus   the   candidates   rbp6,   elav,   and   tis-­11   may   have   a   role   in   small   RNA  
silencing.  
To   confirm   this   hypothesis,   additional   dsRNAs   targeting   different   parts   of   the   three   genes  were  
designed.   Then   both   reporter   cell   lines   were   treated   with   these   triggers   and   the   ones   used   in  
Figure  4-­‐9.  Afterwards   the   fluorescence  was  measured.  Again   the   silencing  of  Ago2  and  Dcr-­‐2   as  
key   factors  of   the  siRNA  machinery   resulted   in  an   increased  GFP  expression  due   to   the   impaired  
exo-­‐siRNA   pathway   (Figure  4-­‐10).   Elav   and   Rbp6,   the   homologues   of  mammalian   HuR   and   AUF,  
respectively,  could  not  be  validated  to  participate  in  siRNA-­‐mediated  gene  silencing.  In  each  case,  a  
de-­‐repression  of  the  fluorescence  signal  of  the  67-­‐1D  cells  was  only  observed  with  the  treatment  of  
one  out  of  two  or  three  dsRNA  respectively  (Figure  4-­‐10A).    
None   of   the   three   different   dsRNAs   directed   against   tis-­11   showed   an   effect   on   the   endo-­‐siRNA  
reporter   cells   (63-­‐N1,   Figure  4-­‐10B).   But   the   treatment   of   67-­‐1D   cells  with   two   out   of   the   three  
tested  triggers  against  tis-­11   resulted  in  a  significant   loss  of  exo-­‐siRNA  mediated  repression.  This  
effect  was  comparable  to  depletion  of  dcr-­2  (2.7-­‐fold  and  2.4-­‐fold  de-­‐repression  of  GFP  in  the  case  
of  dstis-­11   and  dstis-­11_3   vs.   2.1-­‐fold   for  dsdcr-­2).   Taken   together   Tis-­‐11  may   contribute   to   exo-­‐









Figure   4-­‐10:   Silencing   of   the   AUBP   genes   rbp6,   elav   and   tis-­11   with   dsRNA   constructs   targeting  
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  (figure  legend  continued  from  p.49)  
A)  Endo-­‐siRNA   reporter   cells   (63-­‐N1)  and  miR-­‐277   reporter   cells   (67-­‐1D)  were   treated   twice  with  dsRNA  
constructs  indicated  below  the  bars  targeting  rbp6  and  elav.  Ago2  and  Dcr-­‐2  served  as  positive  controls.  GFP-­‐
fluorescence   was   measured   by   flow   cytometry   and   normalized   to   control   knock-­‐down   directed   against  
DsRed.  Values  are  the  mean  of  two  experiments.  The  horizontal  blue  line  marks  no  change  compared  to  the  
control.  
B)  analogous  to  A)  using  three  different  dsRNA  constructs  directed  against  tis-­11.  Values  are  mean  ±  SD  (n=4  
for   63-­‐N1;   n=6   for   67-­‐1D).   These   changes   in   67-­‐1D   cells   were   significant   when   compared   to   the   DsRed  
control  (p<0.08,  student’s  t-­‐test,  n=6).  
  
In   order   to   ensure   that   the   dsRNA   constructs   against   tis-­11   are   reliable,   S2   cells  were   incubated  
with   the   triggers.   After   five   days   RNA   and   proteins   were   isolated.   The   tis-­11   mRNA   level   was  
measured   by   qRT-­‐PCR   using   two   different   sets   of   oligonucleotides.   The   obtained   values   were  
normalized  to  rp49-­‐mRNA  and  a  control  knock-­‐down  (DsRed,  Figure  4-­‐11A).  In  all  three  cases  the  
tis-­11  mRNA  level  was  lowered  to  about  40%  or  less  compared  to  the  control.  Next  the  protein  level  
of  endogenous  Tis-­‐11  after   incubation  with   the  dsRNA  constructs  was  analyzed.  Especially   in   the  
extracts  treated  with  dstis-­11  the  signal  of  Tis-­‐11  was  nearly  completely  diminished  or  significantly  
lowered   for  dstis-­11_3   (Figure  4-­‐11B).  However   in   the   case  of  dstis-­11_2   the  protein   level   is   only  
slightly   lowered.  Therefore,   the   incomplete  depletion  of  Tis-­‐11  protein  could  explain   the  missing  
effect  of  dstis-­11_2  on  67-­‐1D  cells  (see  Figure  4-­‐10B).  
  
  
4.5 tis-­11  has  a  general  effect  on  Ago2-­loaded  RNA  species  
  
In   the   last   chapter   it   was   demonstrated   that   silencing   of   tis-­11   resulted   in   de-­‐repression   of   the  
reporter  in  miR-­‐277-­‐responsive  cells  (67-­‐1D,  Figure  4-­‐10B).  This  raised  the  question  if  this  effect  is  
restricted  to  miR-­‐277  or  also  other  small  RNAs  that  are  loaded  into  an  effector  complex  with  Ago2  
are  affected.  
Therefore   S2   cells   were   transiently   transfected   with   GFP-­‐expression   constructs   targeted   by   the  
miRNA   bantam   and   incubated   with   certain   dsRNAs   (Figure  4-­‐12).   Ban-­‐si   harbours   two   perfect  
matching  sites  for  bantam  in  the  3’-­‐UTR  of  the  GFP  coding  sequence.  It  was  previously  shown  (Shah  
and  Forstemann  2008)  and  after  silencing  of  ago2  easily  visible  that  this  reporter  is  repressed  by  
Ago2-­‐loaded   bantam.   The   measured   fluorescence   was   not   only   normalized   to   a   control   RNAi  





   51  
  
Figure  4-­‐12:  Silencing  of  tis-­11  also  affects  reporter  constructs  targeted  by  Ago-­2  loaded  bantam.  
S2  cells  were  treated  twice  with  dsRNA  constructs  indicated  below  the  bars  targeting  tis-­11,  ago1,  ago2,  dcr-­1  
and   dcr-­2.   Afterwards   they   were   transiently   transfected   with   the   ban-­‐si   reporter   construct.   Ban-­‐si   is  
analogous  to  the  construct  integrated  into  67-­‐1D  cells  (see  Figure  4-­‐10B)  and  carries  two  perfectly  matching  
sites  for  bantam,  instead  of  miR-­‐277,  in  the  3’-­‐UTR  of  GFP.  GFP-­‐fluorescence  was  measured  by  flow  cytometry  
and  normalized   to  control  knock-­‐down  DsRed  and   to   the   transfection  control  pKF63   (GFP  without  binding  
sites   in   its   3’-­‐UTR).   Values   are   the   mean   of   two   experiments.   The   horizontal   blue   line   marks   no   change  
compared  to  the  control.  
  
In  order  to  analyze  if  tis-­11  is  universally  involved  in  exo-­‐siRNA  silencing,  S2  cells  were  treated  with  
dsRNAs   directed   against   components   of   the   small   RNA   pathway   and   tis-­11.   The   cells  were   then  
incubated  with  dsRNA  against  GFP  or  DsRed  as  a  control  and  transfected  with  the  GFP-­‐expression  
vector  pKF63  to  illustrate  the  exo-­‐siRNA  silencing  efficiency  (Figure  4-­‐13A).  Priming  of  Ago2-­‐RISC  
with  dsRNA  directed  against  GFP  will  decrease  in  efficiency  if  the  first  dsRNA  depletes  an  essential  
factor  of  the  exo-­‐siRNA  silencing  pathway.  If  so,  the  GFP  fluorescence  after  pKF63  transfection  will  
increase  (Figure  4-­‐13B).  This  is  the  case  after  silencing  of  ago2  and  dcr-­2  in  the  first  step  compared  
to  the  non-­‐essential  control  DsRed  (55%  and  15%  of  relative  GFP  level,  respectively  compared  to  
1.5%).  Knock-­‐down  of   tis-­11   also   reduced   the   efficiency  of   exo-­‐siRNA  silencing,   resulting   in  11%  
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than   the   de-­‐repression   of   GFP   when   only   one   factor   is   depleted.   Figure  4-­‐15   depicts   the   GFP  
expression  relative  to  a  control  RNAi  against  DsRed.  Simultaneous  silencing  of  ago2  and  tis-­11  does  
not  enhance  the  de-­‐repressive  effect.  Thus  Ago2  and  Tis-­‐11  function  in  the  same  pathway.  
  
  
Figure  4-­‐14:  Tis-­11  has  an  effect  on  all  Ago2-­loaded  RNA  species.  
The  stable  cell  line  used  in  this  experiment  expressing  Renilla-­‐luciferase  is  known  to  be  a  suitable  reporter  to  
detect   endo-­‐siRNA   response.  RNAi   triggers  were   depicted   below   the   bars.   ago2   and  dcr-­2   as   known  endo-­‐
siRNA   factors   served   as   positive   controls.   Luciferase-­‐activity   was   measured   and   normalized   to   both   the  
internal  control  Firefly-­‐Luciferase  and  to  the  unrelated  RNAi  construct  DsRed.  Values  are  mean  ±  SD  (n=3).  
The  horizontal  blue  line  marks  no  change  compared  to  the  control.  
  
  
4.6 Tis-­11  does  not  affect  Ago1-­mediated  silencing  
  
The  depletion  of   tis-­11   results   in  de-­‐repression  of  GFP   in  Ago2-­‐RISC   reporter   cells   (Figure  4-­‐10B  
and  4-­‐12).  This  led  to  the  question  if  also  Ago1-­‐loaded  RNAs  are  regulated  by  Tis-­‐11.  
S2   cells   were   transiently   transfected   with   reporter   constructs   harbouring   four   partially  
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Ago1   and   Ago2   have   distinct   preferences   for   the   architecture   of   their   target   sites.   Ago1   will  
primarily  silence  a  bulged  match  reporter  while  Ago2  targets  a  perfect  match  reporter   (Shah  and  
Forstemann   2008).   After   two   days   si/miRNA   factors   and   tis-­11   were   depleted   and   fluorescence  
measured   by   flow   cytometry   on   day  7.   The   values  were   then   normalized   to   control   RNAi   and   a  
transfection  control  (pKF63)  to  avoid  differences  due  to  transfection  efficiency.  
Silencing  of  Ago1  and  Dcr-­‐1,  required  for  miRNA  biogenesis  showed  an  increased  GFP  fluorescence  
compared   to   the   control  RNAi  directed   against  DsRed   (Figure  4-­‐16).  However  depletion  of   tis-­11  
could  not  de-­‐repress  the  reporter.  So  Tis-­‐11  has  exclusively  an  effect  on  Ago2-­‐loaded  RNAs  and  not  




Figure  4-­‐15:  Ago2  and  Tis-­11  act  in  the  same  pathway.  
miR-­‐277   reporter   cells   (67-­‐1D)  were   treated  with  RNAi   triggers   against   tis-­11   and  ago2   at   the   same   time.  
RNAi   constructs  were   indicated   below   the   bars.   GFP   fluorescence  was  measured  with   flow   cytometry   and  
normalized  to  control  RNAi  targeting  DsRed.  Values  are  mean  ±  SD  (n=3).  The  horizontal  blue  line  marks  no  
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Figure  4-­‐16:  Tis-­11  does  not  influence  Ago1-­mediated  silencing.  
S2   cells   were   treated   twice   with   dsRNA   constructs   indicated   below   the   bars   targeting   tis-­11   with   two  
different   constructs,   ago1,   ago2,   dcr-­1   and   dcr-­2.   Then   they   were   transiently   transfected   with   the   ban-­‐mi  
reporter  construct.  Ban-­‐mi  harbours  four  bulged  binding  sites  for  bantam  in  the  3’-­‐UTR  of  GFP  and  is  targeted  
by   Ago1-­‐loaded   bantam.   GFP-­‐fluorescence   was   measured   by   flow   cytometry   and   normalized   to   control  
knock-­‐down  DsRed  and  to   the   transfection  control  pKF63  (GFP  without  binding  sites   in   its  3’-­‐UTR).  Values  
are  mean  ±  SD  (n=3).  The  horizontal  blue  line  indicates  a  value  of  1  (=no  change  relative  to  control).  
  
  
4.7 Silencing  of  Tis-­11  does  not  alter  protein  levels  of  Ago2  and  Dcr-­2  
  
To  exclude  the  possibility  that  indirect  effects  on  the  overall  expression  of  Ago2  and/or  Dcr-­‐2  could  
simply   explain   the   effects   of   depleted   Tis-­‐11,   S2   cells   were   incubated   with   dsRNAs   against  
si/miRNA  factors  and  tis-­11.  Subsequently  the  protein  levels  were  visualized  via  Western  blotting.  
Ago2  levels  were  presented  in  Figure  4-­‐17A  and  quantified  relative  to  the  loading  control   -­‐tubulin  
(Figure  4-­‐17B).  Knock-­‐down  of  tis-­11  with  both  constructs  does  not  lead  to  reduced  Ago2  protein  
amounts  compared  to  the  control  RNAi  against  DsRed.  Solely  the  treatment  with  dsago2  diminishes  
the  Ago2  protein.  Dcr-­‐2  protein   levels  were  investigated  with  the  same  procedure  as  used  before  
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showed   no   alteration   in   expression   of   the   miRNA,   which   could   be   explained   by   the   inefficient  
depletion  of  Tis-­‐11  protein  by  this  trigger  (Figure  4-­‐11).  Since  even  when  miR-­‐277  was  expressed  
from   a   heterologous   promotor   its   levels   were   reduced   upon   tis-­11   depletion,   transcriptional  
regulation  cannot  be  the  mechanism.  
Another   possible   explanation   for   the   lowered   levels   of   mature  miR-­‐277   could   be   that   the   miR-­‐
277/277*  duplex  is  not  loaded  into  Ago2  due  to  the  silencing  of  Tis-­‐11.  Consequently  the  miR-­‐277*-­‐
strand  is  not  degraded  anymore  and  hence  accumulates.  An  equivalent  Northern  Blot  as  used  above  
was  probed   for  miR-­‐277*.  However,   there  was  no  enrichment  of   the  passenger  strand  detectable  
(data  not  shown).  We  therefore  conclude  that  the  step  of  loading  is  not  impaired.  
  
  
4.9 The  distribution  of  small  RNAs  loaded  into  effector  complexes  with  
either  Ago1  or  Ago2  is  changed  upon  inhibition  of  tis-­11  
  
DmHen1  (CG12367,  Pimet)  is  the  Drosophila  homologue  of  HEN1  first  discovered  in  plants.  It  has  a  
conserved  RNA  methyltransferase  domain  and  catalyzes  2’-­‐O-­‐methylation  at  the  3’-­‐termini  of  Ago2-­‐
associated   RNAs   (Figure  4-­‐21   and   Figure  2-­‐2B).   This   modification   protects   the   RNA   from  
uridylation  and  subsequent  degradation  by  the  exonucleolytic  machinery  (Ameres,  Horwich  et  al.  ;  
Ji   and  Chen).  Unlike  plant  HEN1,  DmHen1  acts  on  single-­‐stranded  RNA,  which   is  maybe   the   final  
step  in  assembly  of  RISC  after  conversion  of  the  duplex  into  ssRNA  (Horwich,  Li  et  al.  2007;  Saito,  




Figure  4-­‐21:  DmHen1  catalyzes  2’-­O-­Methylation  at  the  3’-­end  of  Ago2-­loaded  RNAs  in  Drosophila.  
The  molecular  structure  of  the  RNA  nucleotide  at  the  3’-­‐end  is  represented.  DmHen1  transfers  a  methylgroup  
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(figure  legend  continued  from  p.63)  
A)   tis-­11,   ago2   and   DsRed  were   silenced   in   S2   cells   and   40μg   of   the   isolated   RNAs   were   exposed   to   β-­‐
elimination.  Untreated  and  treated  RNA  fractions  were  analyzed  by  Northern  blotting.  5  fmol  of  the  miR-­‐277  
DNA  oligo  were  also  loaded.  The  membrane  was  hybridized  with  DNA  probes  against  miR-­‐277  (upper  panel),  
hairpin-­‐derived   endo-­‐siRNA   CG4068B   (second   panel),   and   bantam  miRNA   (third   panel).   2S   rRNA   (bottom  
panel)  served  as  a  control  for  efficiency  of  β-­‐elimination  treatment.  
B)  Quantification  of  the  distribution  between  methylated  (light  blue)  and  unmethylated  (dark  blue)  fractions  
of  the  RNAs  for  miR-­‐277,  CG4068B  and  microRNA  bantam.  Values  are  the  mean  of  two  experiments.  
  
The  isolated  RNA  was  exposed  to  β-­‐elimination  after  depletion  of  tis-­11,  ago2  and  DsRed  via  RNAi  
in  S2  cells.  Figure  4-­‐22A  displays  a  Northern  Blot  with  the  β-­‐eliminated  RNA  probed  for  miR-­‐277,  
CG4068B,  bantam  and  2S  rRNA.  The  distribution  of  unmethylated  and  methylated  fractions  of  the  
RNA  were  quantified  and  displayed  separately  in  Figure  4-­‐22B.  The  miR277/277*  duplex  is  more  
extensively   basepaired   than   typical   miRNA   duplexes   that   are   interrupted   by   mismatches   and  
therefore  predominantly  loaded  into  Ago2  (Forstemann,  Horwich  et  al.  2007).  As  expected  almost  
60%  of  miR-­‐277  are   loaded   into  RISC  with  Ago2  and  methylated  under  control  conditions   (RNAi  
DsRed,   Figure  4-­‐22   upper   panel).   Cellular   concentrations   of   miR-­‐277   were   decreased   after  
depletion   of   ago2.   Under   these   conditions   also   more   Ago1-­‐loaded   miR-­‐277   (+20%)   could   be  
observed  (Figure  4-­‐22  upper  panel).  Interestingly  the  same  is  true  after  silencing  of  tis-­11.  The  level  
of  miR-­‐277  is  lowered  and  also  the  stabilization  of  the  RNA  is  clearly  diminished.  Hence  more  Ago1-­‐
loaded  RISC  complexes  were  programmed  (Forstemann,  Horwich  et  al.  2007).  
A  similar  behaviour  can  be  observed  for  the  hairpin-­‐derived  endo-­‐siRNA  CG4068B  that  is  primarily  
associated  with   the   Ago2-­‐effector   complex   (90%)   and   therefore  methylated   (Figure  4-­‐22   second  
panel).   Again   dstis-­11   and   dsago2   result   in   higher   fractions   of   unmethylated   RNA   species  
respectively.   The   miRNA   bantam   is   described   to   be   predominantly   loaded   into   RISC   with   Ago1  
(80%)   and  hence   prone   to  β-­‐elimination   (Okamura,   Ishizuka   et   al.   2004).   Silencing   of   tis-­11   and  
ago2   do   not   change   this   distribution   (Figure  4-­‐22   third   panel).   All   together   Tis-­‐11   seems   to   be  
involved  either  in  the  loading  of  the  RNA  into  RISC  or  the  proper  function  of  DmHen1.  
  
4.10 Tis-­11  is  transiently  associated  with  Ago2  and  Dcr-­2  
  
In   order   to   over-­‐express   Tis-­‐11   in   S2   cells   the   sequences   of   both   isoforms   with   a   N-­‐terminal  
tandem-­‐myc-­‐tag  were  inserted  into  a  Drosophila  expression  vector.  A  tubulin-­‐promotor  drives  the  









Figure  4-­‐24:  Overexpression  of  Tis-­11  does  not  lead  to  a  hyper-­repression  of  Ago2-­reporter  cells.  
A)  Endo-­‐siRNA  reporter  cells  (63-­‐N1)  were  transfected  with  plasmids  overexpressing  miR-­‐277  (pKF84),  Tis-­‐
11PA  (pSH13),  Tis-­‐11PB  (pSH15)  and  the  unrelated  control  pUC18.  GFP-­‐fluorescence  was  measured  by  flow  
cytometry  and  normalized  to  the  control  pUC18.  Values  are  mean  ±  SD  (n=3).  The  horizontal  blue  line  marks  
no  change  compared  to  the  control.  
B)  analogous  to  A)  using  miR-­‐277  reporter  cells  (67-­‐1D),  with  two  perfectly  matching  sites  for  miR-­‐277  in  the  
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4.12 Generation  of  transgenic  flies  over-­expressing  Tis-­11  in  vivo  
  
The  UAS/Gal4-­‐system   from  yeast   could   be   used   for   expression   of   almost   any   gene   of   interest   in  
Drosophila.  A  big  advantage  of  this  system  is  the  possibility  to  activate  the  expression  of  a  gene  only  
in  special  cell   types  or  at  a  specific  time  point.  There  exist  many  different  fly   lines  expressing  the  
yeast  transcription  factor  Gal4  under  the  control  of  a  tissue-­‐specific  promotor.  Mating  these  Gal4-­‐
driver-­‐lines   to   strains   carrying   the   sequence  of   gene  X   fused   to   an  upstream  activating   sequence  
(UAS)  element  start  the  expression  of  gene  X  in  the  particular  cell  types.  Gal4  binds  with  its  DNA-­‐
binding  domain   to   the  UAS-­‐element  and   induces   transcription  of  gene  X  via   its  activation  domain  
(Figure  4-­‐32).  The  effects  of  gene  X  could  then  be  studied  in  the  progeny  (St  Johnston  2002).  
  
  
Figure  4-­‐32:  Gal4-­UAS  system  for  directed  gene  expression.  
Flies  carrying  a  transgene  with  a  UAS-­‐promotor  element  are  mated  with  a  driver  line,  encoding  for  the  yeast  
transcription   factor   Gal4   in   a   tissue-­‐specific   manner.   The   gene   of   interest   is   activated   in   the   offspring.  
Adapted  from  (St  Johnston  2002).  
  
The   bacteriophage   C31-­‐integrase   system   is   an   efficient   tool   to   insert   P-­‐elements   at   a   specific  
position   in   the  Drosophila   genome   and  hence   generate   transgenic   flies.   To   obtain   a   non-­‐random  
integration,   a   characterized   attP-­‐landing   site   (phage-­‐attachment   site)   in   the   genome   and   the  
integration  vector   carrying   the   complementary   attB-­‐site   (bacterial-­‐attachment   site)   are   required.  
The  vector  carrying  the  transgene  and  the  attB-­‐sites  is  injected  into  recipient  embryos  harbouring  
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flanked  by  imperfect  repeats.  The   C31-­‐integrase  is  endogenously  expressed  in  germ  cells  via  the  
vasa  promotor  and  after  the  recombination  the  attB  and  attP  sites  are  no  longer  substrates  for  the  
integrase.  The   integration  occurs  at   the  provided   landing  site  with  a  high  degree  of  specificity,   to  
enable   site-­‐specific   integration   of   the   transgene.   Over   one   hundred   fly   lines   with   installed   attP-­‐
landing   sites   throughout   the   genome   are   generated   and  molecularly   characterized   (Figure  4-­‐33,  
(Bischof,  Maeda  et  al.  2007;  Bischof  and  Basler  2008).  
  
  
Figure  4-­‐33:  Schematic  overview  of  ΦC31-­mediated  integration.  
ΦC31  integrase  mediates  recombination  between  attP  site  in  the  Drosophila  genome  and  the  attB  site  present  
on  a  vector.  This  allows  site-­‐specific  integration  of  any  gene  of  interest  in  the  Drosophila  genome  in  order  to  
generate  transgenic  flies.  Adapted  from  (Fish,  Groth  et  al.  2007).  
  
Transgenic  flies  were  generated  to  express  both  isoforms  of  Tis-­‐11  with  a  N-­‐terminal  tandem-­‐myc-­‐
tag   under   the   control   of   the  UAS/Gal4-­‐system.  The   coding   sequences   of   Tis-­‐11  PA   and  Tis-­‐11  PB  
were   inserted   in   the   pUAST-­‐attB   vector   and   transfected   in   S2   cells   together   with   a   plasmid  
expressing  Gal4  under   the  control  of  a   tubulin-­‐promotor.  After   three  days  proteins  were   isolated  
and   analyzed   by   Western   blotting   (Figure  4-­‐34A).   The   signal   intensity   of   the   antibody   directed  
against   the  myc-­‐tag  demonstrates   that  both   isoforms  are  highly  expressed.  So   the  plasmids  were  
sent   for   embryo   injection   and   a   couple   of   homozygous   fly   lines  were   recovered   for   each   Tis-­‐11  
isoform.  
These  flies  were  crossed  to  different  Gal4-­‐driver-­‐lines,  which  express  Gal4  and  consequently  Tis-­‐11  
in   a   tissue-­‐specific  manner.   An   expression   of   both   Tis-­‐11   isoforms   in   the   nervous-­‐system   (elav-­‐
Gal4)   and  ubiquitously   (actin-­‐Gal4)  has   deleterious   effects   in   the   fly   and   leads   to   an   early   larval  
lethality   (data   not   shown).   Furthermore,   muscle-­‐specific   over-­‐expression   (mhc-­‐Gal4)   of   Tis-­‐11  
leads   to   a   drastic   delay   in   the   development   and   the   offspring   hatched   not   until   about   16  days  
(compared  to  10  days  in  wild  type,  data  not  shown).  Additionally  they  showed  a  severe  phenotype  
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driver   line  showed  early  embryonic   lethality.  Further   the  offspring  of  Mef2-­‐Gal4   (muscle-­‐specific  
expression   of   Gal4)   was   unable   to   finally   hatch   out   of   the   pupae.   Using   the   second  
VDRC  line  101765  the  progeny  was  viable  in  both  cases,  but  the  knock-­‐down  of  tis-­11  was  not  very  
efficient  (data  not  shown).  The  hairpins  expressed  from  the  RNAi-­‐lines  differ  clearly  in  the  number  
of  trinucleotide-­‐repeats  they  contain.  VDRC  line  12259  includes  14  CAN-­‐repeats  and  is  predicted  to  
have  621  off-­‐targets.   Interestingly  ago2   is   not   among   them.   In   contrast   to   VDRC  line  101765  has  
just  2  CAN-­‐repeats  and  did  not  target  other  mRNAs  besides  tis-­11.  So  it  is  likely  that  a  trans-­‐effect  
on  other  mRNAs  led  to  this  severe  phenotype  of  VDRC  line  12259.  
  
  
Figure  4-­‐37:  RNAi  in  Drosophila.  
Gal4-­‐UAS   system  can  drive   the   expression  of   a  double-­‐stranded  hairpin  RNAs.  These   are  processed  by   the  




4.15 Repetitive  sequences  in  the  transcripts  of  both,  tis-­11  and  ago2,  
imply  an  indirect  effect  after  depletion  of  tis-­11  on  the  small  RNA  
machinery  due  to  reduced  ago2-­mRNA  levels  
  
So   far,   all   observations   place   Tis-­‐11   in   an   identical   position   as   Ago2   with   respect   to   siRNA  
biogenesis.  We  therefore  assessed  any  potential  off-­‐target  effects  to  exclude  indirect  modulation  of  
Ago2  levels.  (CAN)n-­‐repeats  are  present   in  many  transcripts,  and  both  ago2  and  tis-­11  are  among  
them  (Ma,  Creanga  et  al.  2006).  Before  it  was  already  shown  that  the  protein  level  of  Ago2  did  not  
change  after  RNAi  against  tis-­11  (Figure  4-­‐17A).    
To   this  end,   the  mRNA  level  of  ago2  was  measured  after  depletion  of   tis-­11.  Therefore,  Ago2  and  









Figure  4-­‐38:  Silencing  of  tis-­11  reduces  also  ago2-­mRNA  levels.  
A)  S2  cells  were  treated  twice  with  RNAi  triggers  dstis-­11,  dstis-­11_3,  dsago2  and  dsDsRed  as  control.     RNA  
was  isolated,  reverse  transcribed  and  the  tis-­11  mRNA  level  was  measured  by  qRT-­‐PCR  to  verify  the  silencing  
of  tis-­11.  The  values  represent  the  fold  change  of  each  RNA  (normalized  to  rp49)  and  control  cells  (DsRed).  
Values  are  mean  ±  SD  (n=3).  The  horizontal  blue  line  indicates  a  value  of  1  (=no  change  relative  to  control).    
B)  analogous  A)  ago2-­‐mRNA  level  was  determined.  The  changes  after  depletion  of  tis-­‐11  were  significant  
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levels  were   determined  by   qRT-­‐PCR   and   normalized   to   the   ribosomal   rp49-­‐mRNA.   Figure  4-­‐38A  
demonstrates  the  efficient  knock-­‐down  of  tis-­11-­‐mRNA  with  both  dsRNAs  dstis-­11  and  dstis-­11_3.  
The  RNAi  trigger  dstis-­11_3  showed  a  slight  reduction  of  ago2  compared  to  the  control,  but  with  a  
high  variability.  However  after  depletion  of  tis-­11  with  the  construct  dstis-­11  only  50%  of  the  initial  
ago2-­‐mRNA  level  was  retained  (Figure  4-­‐38B).    
Consequently  a  new  pair  of  dsRNAs  directed  against  tis-­11  was  designed,  which  did  not  target  the  
glycine-­‐  and  glutamine-­‐rich   regions.  Like   in   chapter  4.4  63-­‐N1  and  67-­‐1D  cells  were   treated  with  
these   triggers  (dstis-­11_4  and  dstis-­11_5)  separately  and  a  mixture  of  both  dsRNAs  (dstis-­11_4+5).  
After   6  days   GFP   intensity   was   measured   and   normalized   to   the   control   DsRed   (Figure  4-­‐39).  




Figure   4-­‐39:   RNAi   triggers   targeting   (CAN)n-­repeats   in   the  mRNAs   of   both   tis-­11   and   ago2   leads   to  
unwanted  off-­target  effects.  
Endo-­‐siRNA   reporter   cells   (63-­‐N1)   and   miR-­‐277   reporter   cells   (67-­‐1D)   were   treated   twice   with   dsRNA  
constructs  indicated  below  the  bars  targeting  non-­‐repetitive  regions  of  tis-­11.  Ago2  served  as  positive  control.  
GFP-­‐fluorescence  was  measured  by  flow  cytometry  and  normalized  to  control  knock-­‐down  directed  against  
DsRed.  Values  are  the  mean  of  two  experiments.  The  horizontal  blue  line  marks  no  change  compared  to  the  
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Taken  together  this   leads  to  the  conclusion  that  at   least  part  of   the  effects  detected  and  analyzed  
after  depletion  of   tis-­11   so   far  are  a  consequence  of   the   lowered  ago2-­‐mRNA   level  by  an   indirect  
effect.  Only  two  out  of  five  dsRNA  constructs  directed  against  tis-­11  resulted  in  a  de-­‐repression  of  
GFP  in  the  exo-­‐siRNA  reporter  cells  (67-­‐1D).  Unfortunately  both  target  the  repetitive  regions  of  the  
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5. Discussion  
  
5.1 Factors  of  the  small  RNA  silencing  pathway  are  not  required  for  AMD  
in  Drosophila  and  mammals  
  
Our   findings   that   AMD   can   occur   independently   of   the   small   RNA   pathway   in   Drosophila   cells  
contradict  a  former  publication  (Jing,  Huang  et  al.  2005).  In  their  manuscript  S2  cells  were  screened  
in   order   to   identify   genes   that   are   required   for   decay   of   β-­‐globin   reporter   transcripts   with  
mammalian  3’-­‐UTRs  harbouring  AREs  (identical  to  the  3’-­‐UTRs  we  used).  They  found  that  Dicer-­‐1,  
Ago1   and   Ago2   were   required   for   ARE-­‐mRNA   degradation   in   Drosophila   and   that   miR-­‐289   is  
responsible   for   recognition   of   ARE-­‐sequences.   Jing   and   colleagues   conclude   that   cooperation   of  
AUBPs  and  the  miRNA  system  is  substantial  for  recognition  of  AREs  and  triggering  mRNA  decay.  In  
contrast  we   could   show   that   AMD   did   not   universally   depend   on   components   of   the   small   RNA  
decay   machinery   (Figure  4-­‐4,   Figure   4-­‐6).   Moreover   a   recent   publication   demonstrated   that  
depletion   of   Ago1   and   Ago2   in   S2   cells   did   not   stabilize   reporter   constructs   containing   AREs   of  
mouse   IL-­‐3   in   its   3’-­‐UTR,   indicating   that   in   general   Ago   proteins  were   not   required   for   AMD   in  
Drosophila  (Spasic,  Friedel  et  al.).  
Additionally  Jing  et  al.  claimed  that  this  mechanism  is  conserved,  because  in  mammalian  cell  culture  
TNF-­‐α  transcripts  were  stabilized  in  a  Dicer-­‐  and  miR-­‐16-­‐  dependent  manner.  miR-­‐16  had  to  bind  
to  ARE-­‐sequences  and  recruit  RISC  and  TTP,  which   leads   to  destabilization  of   the  mRNA.  Our  co-­‐
authors  Johanna  Schott  and  Georg  Stoecklin  (Helfer,  Schott  et  al.)  addressed  the  question  if  miRNAs  
in   general   are   required   for   the   activity   of   TTP   in   mammalian   AMD.   Therefore   they   used   dicer-­‐
deficient  mouse  embryonic   fibroblasts   (MEFs)   to  measure   the  decay  rate  of   ier3-­‐mRNA,  a  known  
target  of  TTP  (Glasmacher,  Hoefig  et  al.  ;  Lai,  Parker  et  al.  2006).  In  contrast  to  WT-­‐MEF  cells,  these  
mutant  MEFs  were  not  able  to  process  mature  miR-­‐16.  They  could  observe  that  degradation  rates  
of   ier3-­‐transcript  are  indistinguishable  in  dicer-­‐deficient  and  WT-­‐cells.  Summing  up  neither  Dicer  
nor  miR-­‐16  were   required   for   ier3-­‐mRNA  decay.  These   findings   provide   further   support   for   our  
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5.2 Technical  differences  between  our  study  and  the  publication  of  Jing  
et  al.  could  not  account  for  the  deviating  results  
  
There  are  several  technical  differences  between  our  study  and  the  one  of  Jing  and  colleagues  that  
had  to  be  mentioned.  First  they  determined  mRNA  half-­‐lives  by  qRT-­‐PCR  whereas  our  analysis  in  S2  
cells  is  based  on  reporter-­‐protein  expression  and  steady-­‐state  mRNA  levels.  Basically  it  is  possible  
that  components  of  the  small  RNA  system  destabilize  ARE-­‐mRNAs  and  increase  their  transcription  
or   translation   rate  at   the   same   time.  Especially   the   interplay  of  miRNAs  and  ARE-­‐sequences  was  
previously  shown  in  another  context.  In  mammals  miRNAs  were  able  to  switch  from  repression  to  
activation  and  stimulate  translation  of  ARE-­‐transcripts  upon  cellular  stress  (Vasudevan  and  Steitz  
2007;  Vasudevan,  Tong  et  al.  2007).  On  the  other  hand  since  almost  five  years  no  more  data  were  
published  based  on  these  revolutionary  findings.  This   led  to  speculations  that  these  reports  were  
somehow  questionable,  too.  
In  our  study  such  a  compensating  effect  by  stimulation  of   transcription  or   translation   is  unlikely,  
since   the   same   extent   of   de-­‐repression   at   protein   and  mRNA   level  was   observed   for  GFP-­‐3xARE  
reporter  (Figure  4-­‐3,  Figure  4-­‐5).  
Second,   the   3’-­‐UTRs   in   the   publication   of   Jing   et   al.  were   attached   to   β-­‐globin  mRNA,  whereas   a  
fusion  with   GFP  was   used   in   our   experiments.   The   choice   of   a   reporter   is   important   and  might  
account   for   small   differences,   but   it   is   unlikely   that   ARE-­‐function   is   completely   diminished.   We  
could  show  that  insertion  of  authentic  and  artificial  ARE-­‐sequences  into  the  3’-­‐UTR  of  GFP  indeed  
lowered  the  stability  of  the  transcripts.  Furthermore,  GFP-­‐reporters  have  already  successfully  been  
used   for   analysis   of   AMD   in  mammalian   cells   (Benjamin,   Colombi   et   al.   2006).   Also   insertion   of  
miRNA  target  sites  into  the  3’-­‐UTR  of  GFP  led  to  robust  repression  indicating  that  RISC  can  access  
this   region   of   the   transcript   (see   Figure   4-­‐7A   and   (Forstemann,   Horwich   et   al.   2007;   Shah   and  
Forstemann  2008).  
Finally   different   promotors   were   used   to   express   the   reporter   genes,   that   resulted   in   different  
steady-­‐state   levels   of   reporter   mRNA.   Our   system   was   previously   used   to   detect   miR-­‐mediated  
repression  (Forstemann,  Horwich  et  al.  2007;  Shah  and  Forstemann  2008)  and  the  de-­‐repression  of  
the  GFP-­‐reporter  after  depletion  of   tis-­11   (see  Figure  4-­‐3)   indicated   that   the  system  has  not  been  
saturated.  
Taken   together   our   data   and   that   obtained   from  mammalian   cell   culture   (Helfer,   Schott   et   al.   ;  
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for  ARE-­‐mediated  mRNA  decay.  However   it   is   not   completely  excluded   that  ARE  and  small  RNA-­‐
binding  sites  may  cooperate  or  interfere  with  each  other  in  the  context  of  a  specific  transcript.  
  
  
5.3 Over-­expression  of  Tis-­11  leads  to  a  dominant-­negative  effect  in  flies  
  
Over-­‐expression   of   Tis-­‐11   in   the   whole   fly   or   specifically   the   nervous   system   led   to   lethality   in  
transgenic   flies   (see   chapter  4.12).   Compared   to  wildtype   flies   they   showed   an   extreme  delay   in  
development  when  Tis-­‐11  is  over-­‐expressed  in  muscle  tissue.  And  they  exhibit  the  so  called  erect  
wing  (ewg)  phenotype.  These  flies  have  severe  abnormalities  in  the  indirect  flight  muscles,  which  
results  in  protruding  wings  (DeSimone,  Coelho  et  al.  1996).  According  to  gene  ontology  categories  
Drosophila  ARE-­‐mRNAs  were  not  enriched  in  muscle  developmental  processes   (Cairrao,  Halees  et  
al.  2009).  So  Tis-­‐11  may  act  at  an  earlier  time  point  during  cell  growth.    
Mainly   cellular   and  developmental   processes  were   regulated  by  ARE-­‐mRNAs.   In   addition  several  
signaling  pathways  can  be  adjusted  by  the  action  of  transcripts  containing  AREs.  As  already  shown  
in  human  cells,  genes  encoding  transcription  factors  were  also  enriched  in  ARE-­‐mRNAs  (Bakheet,  
Williams   et   al.   2006).   It   was   demonstrated   that   Tis-­‐11   regulates   the   level   of   the   antimicrobial  
peptide  CecA1  (Lauwers,  Twyffels  et  al.  2009)  and  the  question  arose  if  it  is  perhaps  even  a  general  
posttranscriptional  regulator  of  immune  genes  in  Drosophila  and  led  to  this  severe  phenotypes.    
  
  
5.4 Identification  of  novel  components  in  the  Drosophila  small  RNA  
silencing  system  using  genomewide  screens  
  
In  the  publication  of  Dorner  et  al.  a  genomewide  screen  was  adopted  in  order  to  identify  genes  that  
affect  the  RNAi  response  in  Drosophila  cell  culture  (Dorner,  Lum  et  al.  2006).  They  used  the  dual-­‐
luciferase  reporter  system  to  monitor  RNAi-­‐mediated  response.  S2  cells  were  treated  with  a  library  
of   different   dsRNAs   (approx.   20,000  dsRNAs),   transiently   transfected   with   luciferase-­‐reporter  
plasmids  and  a  dsRNA  directed  against  Renilla-­‐luciferase.  In  case  the  first  dsRNA  construct  depletes  
an   essential   factor   of   the   RNAi   machinery,   silencing   of   Renilla-­‐luciferase   is   impaired   and   the  
reporter  will   be  de-­‐repressed   (in  principle   similar   to   the   approach  we  used   in  Figure  4-­‐13A).  As  
expected   depletion   of   ago2   led   to   increased   luminescence,   but   this   system   failed   to   identify   a  
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that  their  screen  was  not  comprehensive  in  its  identification  of  components  that  were  essential  in  
the   RNAi   silencing   system,   but   nevertheless   some   new   candidate   genes  might   emerge.   After   re-­‐
screening   with   newly   synthesized   RNAi   triggers   25  interesting   candidate   genes   were   identified,  
which  potentially  are  important   in  small  RNA  silencing.   In  some  of   the  candidate  genes  repetitive  
sequences  were   found.   Hence   it   was   indispensable   to   generate   dsRNAs   directed   against   distinct  
parts  of  the  genes.  Tis-­‐11  was  one  of  the  candidates  that  also  carries  highly  repetitive-­‐regions.  Two  
RNAi   triggers   against   Tis-­‐11   target   the   glycin-­‐glutamine-­‐rich   regions   and   resulted   in   a   clear   de-­‐
repression  of  the  reporter  (19-­‐fold  and  15-­‐fold  de-­‐repression  compared  to  RNAi  directed  against  an  
unrelated  control).  A  third  dsRNA,  which  was  not  directed  against  the  repetitive  regions  of   tis-­11,  
showed  only  a  modest  effect  on  the  luciferase-­‐reporter  system  (2-­‐fold  de-­‐repression  compared  to  
the  control).  
Besides  that,  Dorner  and  colleagues  analyzed  mRNA-­‐  and  protein-­‐levels  of  Ago2  after  silencing  of  
the  candidate  genes  to  exclude  indirect  effects  on  the  overall  Ago2  expression.  Ago2  protein  levels  
did  not  change  compared  to  the  control  when  tis-­11  is  depleted.  The  same  was  concluded  for  ago2-­‐
mRNA  levels,  which  were  examined  by  Northern  blotting.  Nonetheless,  a  reduction  in  ago2-­‐mRNA-­‐
levels   of   40%  ±   10%  was   determined.   Furthermore   it  must   be   added   that   they  did   not  mention  
which  dsRNA  construct  out  of  the  three  was  used  for  these  evalutions.  
Another  report  (Zhou,  Hotta  et  al.  2008)  applied  S2  cells  stably  expressing  Renilla-­‐luciferase  and  a  
hairpin-­‐construct  with  appropriate  sequence  that  is  cleaved  by  Dicer  and  thereby  generates  siRNAs  
directed  against  Renilla-­‐luciferase.  A  collection  of  approx.  21,000  dsRNAs  was  screened  to  identify  
novel   components   that   have   an   impact   on   the   siRNA   pathway.   Like   in   the   former   publication  
additional   independent  dsRNAs  were  generated  to  avoid  potential  off-­‐target  effects  due   to  highly  
repetitive  regions.  Only  genes  targeted  by  at  least  two  independent  dsRNAs  that  showed  an  effect  
on  the  reporter  system  were  scored  as  final  candidates.  To  validate  their  system  they  found  dcr-­2  
and   ago2   among   the   essential   genes   for   the   siRNA   pathway.   All   together   116   candidates   were  
identified  which  de-­‐repressed  the  luciferase-­‐reporter,  however  tis-­11  is  not  among  them.  
To   sum   up   two   genomewide   screens  were   performed   in  Drosophila   S2   cells   in   order   to   identify  
novel  components  of  the  small  RNA  silencing  pathways.  Tis-­‐11  was  only  detected  in  the  approach  of  
Dorner  et  al.  Though  the  screen  of  Zhou  et  al.  was  more  sensitive  (116  discovered  candidate  genes  
for  the  siRNA  pathway  vs.  25  candidates)  it  failed  to  identify  Tis-­‐11.  In  retrospect,  parts  of  the  data  
published   of   Dorner   and   colleagues   need   to   be   interpreted   with   caution.   First   candidate   genes  
enriched  in  repetitive  sequences  were  over-­‐represented  in  their  screen  and  they  failed  to  identify  
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repetitive   regions  of   its  gene  showed  clear  effects  on   the   reporter   (15-­‐  19-­‐fold  de-­‐repression).   In  
contrast,   the  de-­‐repression  after  depletion  of   tis-­11   using   the   third  RNAi   trigger  directed  against  
non-­‐repetitive   sequences   had   barely   an   effect   (2-­‐fold   de-­‐repression),   which   might   be   negligible  
despite  it  being  statistically  significant.  Finally  they  mentioned  nowhere  in  their  report  which  RNAi  
trigger  directed  against  tis-­11  was  used  to  verify  that  the  levels  of  Ago2-­‐protein  and  mRNA  did  not  
change  after  the  treatment.  
  
  
5.5 Not  all  effects  after  depletion  of  Tis-­11  can  be  explained  by  indirect  
regulation  of  Ago2  expression  
  
Basically  most  of  our  observations  set  Tis-­‐11  in  the  same  position  as  Ago2  with  regard  to  the  RNAi  
pathway.  Though  we  had  observed  before  that  after  silencing  of  tis-­11  with  both  RNAi  triggers  tis-­
11   and   tis-­11_3   the   protein   levels   of   Ago2   remained   unchanged   (Figure  4-­‐17),   we   decided   to  
measure   also   the   ago2-­‐mRNA   levels.   Only   10%   ago2-­‐mRNA  was   left   after   using   dsRNA   directed  
against  ago2.  While  the  amount  of  ago2-­‐mRNA  was  only  slightly  lowered  (ca.  15%)  using  dstis-­11_3,  
treatment  with  dstis-­11  reduces  the  ago2-­‐mRNA  level  clearly  by  50%  (Figure  4-­‐38).    
This  could  explain  the  effect  on  the  ban-­‐si-­‐reporter  constructs  after  silencing  tis-­11   (Figure  4-­‐12).  
Because  depletion  of  tis-­11  using  the  RNAi  triggers  tis-­11  (50%  ago2-­‐mRNA  indirectly  targeted)  and  
tis-­11_3  (15%  ago2-­‐mRNA  targeted)  led  to  a  3-­‐fold  and  1.5-­‐fold  de-­‐repression  of  GFP  respectively.  
This   is   in   a   comparable   range  with   the   6-­‐fold   increase   in   fluorescence   after   the   nearly   complete  
knock-­‐down  of  ago2  (only  10%  ago2-­‐mRNA  left).  The  same  is  true  regarding  the  effect  of  Tis-­‐11  on  
the  luciferase  reporter  suitable  to  detect  endo-­‐siRNA  mediated  silencing  (Figure  4-­‐14).  Silencing  of  
ago2   resulted   in   a   2.5-­‐fold   increase   of   luminescence   compared   to   1.5-­‐fold   de-­‐repression   after  
knock-­‐down  of  tis-­11  (dstis-­11).  Also  the  inhibition  of  exo-­‐siRNA  silencing  after  depletion  of  tis-­11  
(Figure  4-­‐13)   could   be   explained   with   the   indirect   modulation   of   ago2-­‐mRNA   expression   levels  
(60%   silencing   activity   inhibited   after   knock-­‐down  ago2   vs.   15%  after  dstis-­11).   Finally   only   the  
biogenesis  of  Ago2-­‐loaded  RNAs,  miR-­‐277  and  endo-­‐siRNA  CG4068B  was  blocked  in  tis-­11  depleted  
cells  (Figure  4-­‐19).  And  the  distribution  of  miR-­‐277  and  CG4068B  between  effector  complexes  with  
Ago2  or  Ago1  after  knock-­‐down  of  tis-­11  showed  basically  the  same  pattern  as  ago2-­‐depleted  cells  
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Nevertheless  several  effects  could  not  solely  be  explained  with  lowered  levels  of  ago2-­‐mRNA.  For  
example   the   impact   on   67-­‐1D   cells   after   knock-­‐down   of   tis-­11   led   to   a   3-­‐  4.5-­‐fold   de-­‐repression  
using   dstis-­11   construct   and   2.5-­‐fold   using   dstis-­11_3.   In   contrast   to   this,   depletion   of   90%   ago-­‐
mRNA   resulted   only   in   a   5-­‐  6-­‐fold   increase   of   GFP   fluorescence,   which   is   not   quantitative  
comparable  (Figure  4-­‐9B,  Figure  4-­‐10B,  Figure  4-­‐15).  On  the  other  hand  the  three  dsRNA  triggers  
which  target  the  non-­‐repetitive  regions  of  tis-­11  showed  no  effect  on  67-­‐1D  reporter  cells  (Figure  4-­‐
10B,  Figure  4-­‐39).    
Taken  together  not  all  effects  we  had  observed  could  be  explained  by  indirect  modulation  of  Ago2  
expression.   But   it   is   not   possible   to   separate   them.  Unfortunately  most   of   the   experiments  were  
done  using   the  dsRNAs  which   target   the   (CAN)n-­‐repeat-­‐regions  of   tis-­11   and   therefore   it   is   likely  
that  they  cause  many  off-­‐target  effects.  
  
  
5.6 Common  strategies  to  minimize  off-­target  effects  and  validation  of  
knock-­down  specificity  
  
In   many   organisms   RNAi   became   a   powerful   tool   to   perform   studies   where   gene   function   is  
specifically   inhibited.   Large   dsRNAs   are   successfully   used   in   D.  melanogaster   and   C.  elegans   to  
induce  RNAi.  Many  siRNAs  are  generated  from  the  300-­‐800  bp  dsRNAs  by  the  endonuclease  Dicer  
(Seinen,   Burgerhof   et   al.).   But   long   dsRNA   have   the   potential   to   generate   non-­‐specific   off-­‐target  
effects  like  reported  for  short  RNAs  in  mammalian  cells  (Lin,  Ruan  et  al.  2005;  Jackson,  Burchard  et  
al.  2006).  Thus   length  and  sequence  of   the  designed  dsRNAs  are   important   for   specificity.  Highly  
repetitive   or   conserved   regions   should   be   avoided   to  minimize   the   likelihood   of   nonspecific   off-­‐
target  effects.  Genes  containing  these  regions  are  over-­‐represented  in  candidate  lists  from  screens,  
where   they  might   be   part   of   a   huge   class   of   false   positives   (Echeverri   and   Perrimon   2006;  Ma,  
Creanga  et  al.  2006).  
In  mammals  it  is  known  that  dsRNAs  longer  than  30  bp  can  induce  innate  immune  response,  such  
as   interferon   response   (Yang,  Buchholz   et   al.   2002).  To   avoid   this  different  methods   are  used   to  
perform  RNAi  in  mammalian  cells.  
In   most   cases   chemically   synthesized   siRNAs   are   transfected   into   the   cells,   but   can   vary  
dramatically   concerning   their   silencing   efficiency.   Therefore,   each  mRNA  must   be   screened   for   a  
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RNAs   (shRNAs)   expressed   from   plasmids   or   viral   vectors   (Paddison,   Caudy   et   al.   2002;   Kittler,  
Surendranath  et  al.  2007).  
Another   method   employed   endonucleolytic   cleavage   of   target   specific   long   dsRNAs   by   E.coli  
RNaseIII  in  vitro.  Thereby,  a  diverse  pool  of  siRNAs  is  produced  which  is  named  endoribonuclease-­‐
prepared  siRNAs  (esiRNA)  (Yang,  Buchholz  et  al.  2002;  Kittler,  Surendranath  et  al.  2007).  The  same  
principle  as  before  uses  recombinant  human  Dicer  to  generate  so  called  dicer-­‐generated  siRNAs  (d-­‐
siRNAs;   (Myers,   Jones   et   al.   2003).   They   share   the   same   end-­‐structures,   5’-­‐phosphate,   3’-­‐
hydroxylgroup   and   2  nt-­‐overhangs,   as   usual   siRNAs,   which   are   important   for   RNAi   activity  
(Elbashir,   Martinez   et   al.   2001).   The   diced   siRNA   pools   contain   hundreds   of   individual   siRNAs,  
hence  they  are  able  to  target  multiple  sites  within  one  transcript  (Myers,  Chi  et  al.  2006).  
Both   synthetic   siRNAs   and   diced   siRNAs   mediate   efficient   silencing   of   reporter   constructs   or  
endogenous   targets   (Yang,   Buchholz   et   al.   2002).   But   there   are   differences   comparing   their  
specificity.  Many   synthesized   siRNAs   produce   off-­‐target   effects,  whereas   the   complex  mixture   of  
esiRNAs   leads   to   more   specific   silencing.   Due   to   the   high   complexity   of   diced   siRNAs,   the  
concentration  of  any  individual  problematic  siRNA  is  in  theory  too  low  to  result  in  a  significant  off-­‐
target  effect  (Myers,  Chi  et  al.  2006).  
There   are   different   potential   sources   to   generate   nonspecific   off-­‐target   effects.   High   numbers   of  
siRNAs   can   saturate   the   endogenous   RNAi   machinery   and   thereby   inhibit   the   function   of  
endogenous   miRNAs   (Grimm,   Streetz   et   al.   2006).   Or   one   of   the   strands   can   hybridize   with  
unintended   transcripts.   Already   short   stretches   of   7  nt   can   act   like   a   seed-­‐region   and   cause  
translational   repression   (Jackson,   Bartz   et   al.   2003;   Birmingham,   Anderson   et   al.   2006;   Jackson,  
Burchard  et  al.  2006).  
It   is   not   only   important   to  minimize   the   probability   of   off-­‐target   effects,   but   also   to   validate   the  
specificity  of  a  knock-­‐down.  First,  it  is  essential  to  treat  the  cells  also  with  a  siRNA  directed  against  
an  unrelated  control,  e.g.  DsRed  or  luciferase,  to  guarantee  that  the  observed  phenotype  is  not  an  
indirect  effect.  Second,  two  or  three  different  siRNAs  should  be  designed  that  target  distinct  regions  
of  the  transcript  and  if  the  knock-­‐down  is  specific  all  constructs  should  show  the  same  phenotype.  
Another  possibility   is   to  validate   the  knock-­‐down  by  rescuing   the  mutant  phenotype.  Therefore  a  
resistant  form  of  the  target  mRNA  could  be  artificially  expressed  in  the  cell  (2003;  Moffat,  Reiling  et  
al.  2007).  
During  our  study  we   followed  these  guidelines   to  confirm  specificity  of   the  RNAi   treatments.  The  
cells  were  always  incubated  in  parallel  with  a  control  dsRNA  directed  against  an  unrelated  control,  
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determined   to   validate   its   depletion   and   consequently   exclude   indirect   effects   due   to   global  
translational  repression  (Figure  4-­‐11).  Finally  the  effects  on  the  67-­‐1D  reporter  after  depletion  of  
the  candidate  genes  elav,  rbp6  and  tis-­11  were  tested  with  at  least  two  different  dsRNAs.  However,  
only   the   effect   after   knock-­‐down  of   tis-­11   could   be   confirmed   as   specific   using   two   independent  
RNAi   triggers   (Figure  4-­‐10).   Hence   the   specificity   of   knock-­‐down   tis-­11   could   be   validated.   The  
indirect  modulation  of  ago2-­‐levels  using  these  dsRNA  constructs  was  detected  at  a  later  time  point.  
  
  








°C                                   degrees  Celsius  
∆                                   deletion  
63-­‐N1                       endo-­‐siRNA  cell  culture  reporter  cell  line  
67-­‐1D                      siRNA  cell  culture  reporter  cell  line  
Ago                                 Argonaute  protein  
AMD            AU-­‐rich  mediated  decay  
Amp                                 ampicillin  
AMPeps         antimicrobial  peptides  
APS                                 ammonium  peroxodisulfate  
ARE            AU-­‐rich  element  
ATP                                 adenosine  triphosphate  
AUBP            AU-­‐rich  binding  protein  
Bnl            branchless  
bp                               base  pair(s)  
BSA                                 bovine  serum  albumine  
C-­‐term                             protein  C-­‐terminus  
cDNA                               complementary  DNA  
CecA1            CecropinA1  
CG4068                           hairpin  forming  endo-­‐siRNA  precursor  gene  
co-­‐IP                               co-­‐immunoprecipitation  
CT-­‐value                           cycle  of  threshold  value  in  qPCR  
d                                     day(s)  
D.  melanogaster            Drosophila  melanogaster  
dcr                                   dicer  gene  
Dcr                                   Dicer  protein  
DMSO                             dimethyl  sulfoxide  
DNA                                 desoxy-­‐ribonucleic  acid  
dNTP                               desoxy-­‐nucleotide-­‐tri-­‐phosphate  
ds                                   double-­‐stranded  
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dsRBP                               double-­‐stranded  RNA  binding  domain  protein  
dsRNA                             double-­‐stranded  RNA  
DTT                                 dithiothreitol  
E.  coli                               Escherichia  coli  
ECL                                 Enhanced  Chemiluminescence  
EGFP                               Enhanced  Green  Fluorescent  protein  
Elav            embryonic  lethal,  abnormal  vision  
endo-­‐                               endogenous  
endo-­‐siRNA                    endogenous  small  interfering  RNA  
esi-­‐RNA         endoribonuclease-­‐prepared  siRNAs  
exo-­‐                                 exogenous  
exo-­‐siRNA                         exogenous  small-­‐interfering  RNA  
FACS                               Fluorescence  Activated  Cell  Sorting  
FBS                                 Fetal  Bovine  Serum  
FMR1                               Fragile  Mental  Retardation  Protein  1  
FXR-­‐1              Fragile-­‐X  mental  retardation-­‐related  protein  1  
GFP                                 Green  Fluorescent  Protein  
GM-­‐SCF           granulocyte/macrophage  colony-­‐stimulating  factor  
GST                                 glutathione  S-­‐transferase  
h                                     hour(s)  
Hen1            HUA  Enhancer  1  
  hpRNAs           hairpin  RNAs  
HRP                                 Horseradish  Peroxidase  
Ier3            immediate  early  response  3  
IL              Interleukin  
IP                                     immunoprecipitation  
IPTG                                 Isopropyl-­‐β-­‐D-­‐thiogalactopyranosid  
Kana                               kanamycin  
Ko            knock-­‐out  
Luci                                   luciferase  
MEF            mouse  embryonic  fibroblast  
mg                                   milligram  
miR                                 micro  RNA  
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ml                                 milliliter  
mRNA            messenger  RNA  
N-­‐term                             protein  N-­‐terminus  
Neo                                 neomycin  
ng                                   nanogram  
nt                                   nucleotide(s)  
NTP                                 nucleotide-­‐tri-­‐phosphate  
OD                                   optical  density  
ORF                                 open  reading  frame  
p.a.                                 pro  analysi  
PA/PB/PC/PD                protein  isoform  A/B/C/D  
PAGE                               Polyacrylamide  Gel  Electrophoresis  
PAZ                                 Piwi-­‐Argonaute-­‐Zwille  domain  of  Dicer  and  Argonaute  proteins  
PCR                                 Polymerase  Chain  Reaction  
piRNA                               Piwi-­‐interacting  RNA  
PNK                                 polynucleotide  kinase  
Pol  II                               DNA  polymerase  II  
Poly-­‐A                             poly-­‐adenylation  
PVDF                               Polyvinylidenfluoride  
qPCR                               quantitative  Polymerase  Chain  Reaction  
rb                                   rabbit  
rel.                                   relative  
RISC                                 RNA  induced  silencing  complex  
RLC                                 RISC  loading  complex  
RNA                                 ribonucleic  acid  
RNAi                               RNA  interference  
RNaseIII                           endoribonuclease  class  III  
rRNA            ribosomal  RNA  
RT                                   reverse  transcription  or  real-­‐time  
S2  cell                             Schneider-­‐2  cell  
SD                                   standard  deviation  
siRNA                               small  interfering  RNA  
SOB                                 Super  Optimal  Broth  
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SV40                               Simian  Virus  40  
tech.                               technical  
Tis11            TPA-­‐induced  sequence  11  
TTP            Tristetraprolin  
UAS                                 yeast  Upstream  Activating  Sequence  
UTR                                 untranslated  region  
V                                     Volt  
WT            wildtype  
α                                   anti  
µ                                     micro  
µg                                   microgram  
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